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CHAPTER 1: STUDY OVERVIEW
Somatic symptoms are the leading cause of outpatient medical visits (Kroenke, 2003b). 
One-third to one-half of outpatient primary care visits are for patients who present with elevated 
somatic symptoms that are not clearly explained by a disease or injury process—variously 
labeled medically unexplained symptoms (MUS), “functional” disorders, somatoform disorders 
(Kroenke, 2003a), or somatic symptom disorders (American Psychiatric Association, 2013). 
Other MUS consist of a syndrome or cluster of somatic symptoms for which the etiology is 
poorly understood, such as irritable bowel syndrome (IBS), fibromyalgia, chronic fatigue 
syndrome, temporomandibular disorder, and interstitial cystitis. These somatic syndromes often 
overlap and are similar in terms of psychiatric comorbidity, functional impairment, and family 
history (Aaron & Buchwald, 2001; Henningsen, Zimmermann, & Sattel, 2003; Kroenke & 
Rosmalen, 2006). All are characterized by physical symptoms that are not primarily explained by 
medical conditions (disease, injury, physiological perturbations), and all are associated with 
distress and impairment (Stuart & Noyes, 1999).  
A history of trauma, stressful life events, or psychological conflict is common among 
patients with medically unexplained symptoms. Elevated trauma, stress, and emotional 
dysregulation have been found with patients who have fibromyalgia (Aaron et al., 1996; 
Merskey, 1989), IBS (Thompson et al., 1999; Whitehead, Bosmajian, Zonderman, Costa, & 
Schuster, 1988), pelvic pain (Mathias, Kuppermann, Liberman, Lipschutz, & Steege, 1996), 
headaches (Martin & Theunissen, 1993) multiple chemical sensitivity (Barsky & Borus, 1999), 
and chronic fatigue syndrome (Manu, Lane, & Matthews, 1989; Morrison, 1980). Indeed, 
emotional stressors have been found to precipitate, exacerbate, or prolong many functional 
somatic syndromes (Clauw & Chrousos, 1997; Waylonis & Perkins, 1994).  
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In primary care settings, which is where such presentations are initially and most 
commonly seen, the roles of stress and trauma are commonly ignored or minimized. The medical 
staff typically focuses on medical history, current signs and symptoms, laboratory tests and 
pharmacological interventions in the brief time that they have with the patients (Abbass, Kisely, 
& Kroenke, 2009; Kellner, 1991). Even psychologists in primary care also typically avoid 
directly focusing on trauma and conflict, in favor of assessments that focus on psychiatric 
diagnoses (e.g., anxiety, depression) or lifestyle behavior, and interventions that focus on 
behavior change or symptom management. The diagnosis of somatization is often made by 
indirect methods such as a patient checklist, clinical speculation, or exclusion when other 
biological causes are ruled out (De Gucht & Fischler, 2002). Similarly, existing treatment models 
focus on pain reduction and symptom management (Abbass et al., 2009; Kellner, 1991), but do 
not address stress or emotional dysregulation. Consequently, patients’ basic problems of 
unresolved stressors, trauma, and emotional conflicts, and private struggles (e.g., secrets) are 
often overlooked in primary care (Escobar, Waitzkin, Silver, Gara, & Holman, 1998). This leads 
to prolonging patients’ symptoms and distress and driving continued high utilization (Escobar, 
Swartz, Rubio-Stipec, & Manu, 1991). These problems contribute to the estimated $100 billion 
annually spent on U.S. healthcare (Barsky, Orav, & Bates, 2005). This high utilization renders 
the development of integrative assessment and intervention tools imperative to reverse this 
problem.  
Research suggests that identifying and processing emotions connected to stressful 
experiences, conflicts, and secrets can improve pain and other symptoms. It appears that 
emotional avoidance and failure to process and resolve stressful experiences are core factors that 
prolong and maintain an excessive stress response, which contributes to physical symptoms. For 
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instance, a systematic review found that short-term intensive psychodynamic psychotherapy—an 
intervention that encourages patients to acknowledge and engage with avoided emotions and 
psychological conflicts—has many positive benefits for individuals with somatic symptom 
disorders (Abbass et al., 2009). Evidence also supports the benefits of a conceptually similar 
approach, written emotional disclosure, in a range of patient populations (Frattaroli, 2006; 
Smyth, 1998), including individuals with chronic pain (Lumley, Sklar, & Carty, 2012), such as 
fibromyalgia (Broderick, Junghaenel, & Schwartz, 2005), and chronic pelvic pain (Norman, 
Lumley, Dooley, & Diamond, 2004).  
This research suggests that providing an experiential assessment interview that targets 
emotional and stressful experiences in primary care may be an important approach for patients 
with medically unexplained symptoms. This study tested how a single intensive interview 
focusing on stress, emotions, and emotional avoidance affects the attitudes and symptoms of 
primary care patients with medically unexplained symptom, compared to a waitlist, no-interview 
condition. It was hypothesized that individuals in the interview group would demonstrate greater 
awareness and endorsement of the links between their stress physical symptoms, compared to the 
waitlist control condition. It was also hypothesized that individuals in the interview group would 
experience more improvement in physical symptoms and psychological status, compared to 
those in the waitlist control condition. 
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CHAPTER 2: LITERATURE REVIEW 
The experience of physical symptoms such as pain, fatigue, and dizziness, in the absence 
of disease or injury to fully explain them, is common, disabling, and costly (Abbass et al., 2009; 
Rief & Barsky, 2005). One-third to one-half of outpatient primary care visits are for patients with 
elevated somatic symptoms, medically unexplained conditions, “functional” disorders, 
somatoform disorders (Kroenke, 2003a, 2003b), with recent estimates ranging from 40% to 49% 
(Haller, Cramer, Lauche, & Dobos, 2015). This constellation of physically unexplained 
symptoms is sometimes referred to as “medically unexplained symptoms” (MUS). The broad 
category of MUS includes a variety of conditions including the somatoform disorders described 
in DSM-IV, somatization disorder, pain disorder, conversion disorder, and undifferentiated 
somatoform disorder. According to Abbass (2009), MUS entail individual physical symptoms, 
such as pain (e.g., low back, joint, chest, abdominal, headache) and nonpain (e.g., fatigue, 
dizziness, palpitations) complaints. Others posit that MUS consist of a cluster of somatic 
symptoms for which the etiology is poorly understood, such as irritable bowel syndrome, 
fibromyalgia, chronic fatigue syndrome, temporomandibular disorder, and interstitial cystitis. 
These somatic syndromes often overlap and are similar in terms of psychiatric comorbidity, 
functional impairment, and family history (Aaron & Buchwald, 2001; Henningsen et al., 2003; 
Kroenke & Rosmalen, 2006). All are characterized by physical symptoms that are not primarily 
explained by medical conditions (disease, injury, physiological perturbations), and all are 
associated with distress and impairment (Stuart & Noyes, 1999).  
Medically unexplained somatic symptoms are the leading cause of outpatient medical 
visits (Kroenke, 2003b). The prevalence rate of MUS in primary care is high, ranging from 30% 
to 60% of primary care patients (Stuart & Noyes, 1999). Patients with MUS also have a high 
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prevalence in specialist care and are responsible for a significant proportion of disability in the 
workforce (Barsky et al., 2005; Wessely, Nimnuan, & Sharpe, 1999). Clinically significant 
somatization or unexplained medical symptoms often lead to excessive healthcare use, costing 
the U.S. healthcare system an estimated $100 billion annually (Barsky et al., 2005).   
Prevalence of psychosocial distress in patients with MUS  
In healthcare settings, medically unexplained symptoms are likely related to 
psychological stress and often result in help-seeking behaviors (Kroenke, Spitzer, & Williams, 
2002). Numerous studies suggest that early adverse life experiences contribute to the 
development of somatization in adulthood (Stuart & Noyes, 1999). In particular, childhood 
trauma, including sexual abuse, physical abuse, emotional abuse, and neglect, have been linked 
with somatization in adults (Sansone, Wiederman, & Sansone, 2001; Spertus, Yehuda, Wong, 
Halligan, & Seremetis, 2003), and a wide range of symptoms for which there is no medical 
explanation, including chronic pain (Green, Flowe-Valencia, Rosenblum, & Tait, 2001), 
headaches (Bendixen, Muus, & Schei, 1994), gynecological complaints (Cunningham, Pearce, & 
Pearce, 1988), gastrointestinal symptoms (Bass, Bond, Gill, & Sharpe, 1999), and 
musculoskeletal symptoms (Bendixen et al., 1994). 
A number of studies have documented the relationship between MUS and psychiatric 
disorders. Significantly elevated prevalence rates of psychiatric symptoms and diagnoses were 
found in patients with fibromyalgia (Aaron et al., 1996; Merskey, 1989), irritable bowel 
syndrome (Thompson et al., 1999; Whitehead et al., 1988), patients with multiple chemical 
sensitivities (Barsky & Borus, 1999), and chronic fatigue syndrome (Manu et al., 1989; 
Morrison, 1980). Patients with MUS have increased rates of depression and anxiety (Bass, 
Peveler, & House, 2001; Katon, Sullivan, & Walker, 2001), and distressing somatic symptoms 
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are also increased 2- to 3-fold in patients with depressive and anxiety disorders (Kroenke, 2003a; 
Sha et al., 2005). The mechanism of this association remains unclear and subject to further 
investigation.  
Theories about somatization, stress and health 
These links between somatic symptoms and psychiatric disorders are indicative of the 
role of psychological factors, particularly negative emotions, in inducing or exacerbating somatic 
symptoms. Substantial research suggests that stressful major life events play a role in amplifying 
bodily symptoms, and emotional stressors have been found to exacerbate or precipitate many 
functional somatic syndromes (Clauw & Chrousos, 1997; Waylonis & Perkins, 1994). Research 
shows the coexistence of somatic and depressive symptoms (Herrman et al., 2002; Simon, 
VonKorff, Piccinelli, Fullerton, & Ormel, 1999; Turk, Okifuji, & Scharff, 1995). 
In models of central sensitization (CS), individuals experience excessive sensitivity to 
both painful and nonpainful stimuli, a common symptom shared among individuals with 
medically unexplained syndromes (e.g., fibromyalgia, chronic pelvic pain, headaches). Yunus 
(2008) described CS, attributing it to alterations in the central nervous system (Yunus, 2008). A 
review of studies confirms the links between life stress and CS (Yunus, 2007) and presents 
associations between childhood abuse and CS, such as fibromyalgia and chronic fatigue 
syndrome (Van Houdenhove et al., 2001), IBS (Scarinci, McDonald-Haile, Bradley, & Richter, 
1994), and headaches (Golding, 1999). Childhood adverse experiences may promote long-lasting 
neuronal plasticity that causes both physical and psychological symptoms, as well as central 
sensitization among adults. Finally, trauma has been linked to many CS syndromes (Banic et al., 
2004; Sterling, Jull, Vicenzino, & Kenardy, 2004).  
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Within the trauma literature, theorists have proposed mechanisms by which trauma can 
affect physical symptoms. Andreski and colleagues suggest that among individuals with 
posttraumatic stress disorder (PTSD), psychosocial stress may increase personal vulnerability 
toward experiencing physical symptoms (Andreski, Chilcoat, & Breslau, 1998), potentially 
through the action of inflammatory mediators (Banic et al., 2004; Sterling et al., 2004). It has 
also been suggested that neurobiological changes, increased physiological arousal and poor 
health behaviors in the aftermath of trauma paves the way for somatization (Van Ommeren et al., 
2002). Alternatively, some have argued that the medical problems or physical symptoms are 
often manifestations of emotional conflicts (O'Donohue & Levensky, 2006), and some of these 
emotional conflicts are unconscious and manifest as physical symptoms such as headaches, 
gastrointestinal problems, and pain (Cunningham et al., 1988).  
Experiential and emotional avoidance  
Emotional conflict may lead individuals to become dysregulated, and often these 
individuals experience difficulty in managing stressful situations and are more vulnerable to the 
detrimental effects that stress can have on the body. These individuals often avoid emotional 
experiences due to the threat or fear of the experience or expression of emotion, which then may 
lead to dysregulation. Experiential avoidance refers to a general tendency to avoid any aspect of 
internal experience evaluated as aversive, which may or may not include those internal 
experiences associated with a traumatic event (Hayes, Wilson, Gifford, Follette, & Strosahl, 
1996). It appears that experiential avoidance mechanisms, including emotional suppression, 
inhibition, and failure to process and resolve stressful experiences, are core factors that prolong 
and maintain an excessive stress response, which contributes to physical symptoms through 
various pathways (e.g., brain-based augmentation, muscular tension, somatic preoccupation). For 
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example, a study aimed at identifying stress-mechanisms found that emotional avoidance 
negatively influences the physiology, psychology, and social struggles of patients by causing the 
activation of the sympathetic nervous system. In turn, sympathetic activation causes the body to 
be hypersensitive to stress and adversely affects the ability to relax and sleep deeply, thus 
reducing parasympathetic activity (Lind, Delmar, & Nielsen, 2013).    
It is plausible that experiential avoidance results in patients losing contact with their 
deeper needs, vulnerability, and primary emotions during stressful times, responding to stress 
physiologically and behaviorally rather than emotionally and relationally (Lind et al., 2013). A 
review by Lind and colleagues (2013) shows associations between diagnoses of fibromyalgia or 
somatoform disorder with lack of physical affection and poor emotional relationships with 
parents, as well as physical quarrels between parents (Imbierowicz & Egle, 2003). Research also 
finds a significant association between somatoform disorders and suppression of affect (Gündel 
et al., 2008; Stoeter et al., 2007), and decreased body and emotional awareness (Mehling et al., 
2013; Subic-Wrana, Beutel, Knebel, & Lane, 2010). 
This body of literature underscores the critical role of emotion processes, particularly 
emotional avoidance and suppression, in inducing or exacerbating somatic symptoms. 
Unfortunately, existing assessment and treatment models, particularly in primary care, do not 
address the unresolved stress and emotional dysregulation that result in physical symptoms. 
How are stress and emotional processes currently assessed in primary care?  
One-third to one-half of outpatient primary care visits are for patients with elevated 
somatic symptoms, medically unexplained conditions, “functional” disorders, or somatoform 
disorders (Kroenke, 2003a, 2003b).  Despite this high prevalence of somatization in medical 
settings, it often remains unrecognized (Morriss et al., 1998) or poorly diagnosed. This lack of 
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recognition results in unnecessary testing, admission, surgery, medication, and patient suffering 
(Gask et al., 1991). The diagnosis of somatization is often made by indirect methods such as a 
patient checklist, clinical speculation, or exclusion when other biological causes are ruled out 
(De Gucht & Fischler, 2002). Several screening tools have been developed and utilized in 
medical and research settings. These include screening for elevated somatic symptoms with the 
Patient Health Questionnaire-15 (Kroenke et al., 2002); screening for somatoform symptoms 
(SOMS; Fabião et al., 2010), the Schedule for Evaluation of Persistent Symptoms (SEPS; Helen 
et al., 2013), International Classification of Diseases-10 (ICD-10; WHO), and the General Health 
Questionnaire (Goldberg & Williams, 2000). Other models include estimating the likely 
prevalence of medically unexplained symptoms and severe medically unexplained symptoms in 
a primary care practice when existing patient electronic records suggest increased treatment 
seeking and multiple diagnoses of medically unexplained symptoms (Morriss, Lindson, 
Coupland, Dex, & Avery, 2012). Clearly, these tools do not directly assess the sources of stress, 
emotional avoidance, and primary emotions that underlie some of these physical symptoms, 
rendering the evaluations lacking.  
Similarly, existing treatment models focus on pain reduction and symptom management, 
but they do not address stress or emotional dysregulation (Abbass et al., 2009; Kellner, 1991). In 
primary care settings, which is where such presentations are most commonly seen, the role of 
stress and trauma is commonly ignored or minimized in patient interviews by the medical staff. 
Instead, perhaps understandable given the brief time they have with patients, medical staff 
typically focus on biological illness, laboratory tests and subsequent pharmacological 
interventions (Abbass et al., 2009; Kellner, 1991). Even psychologists in primary care typically 
do not directly focus on trauma and conflict, in favor of assessment that focuses on psychiatric 
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diagnoses or distress (e.g., anxiety, depression), lifestyle behavior, and brief symptom 
management interventions. Consequently, patients’ basic problems of unresolved stressors, 
trauma, and emotional conflicts, including secrets, are often overlooked in primary care (Escobar 
et al., 1998), and the entire system suffers from excessive costs and utilization (Escobar et al., 
1991). This problem renders the development of integrative assessment tools imperative to 
reverse this problem.  
Additionally, there may be a tacit understanding by the patient that psychological 
symptoms are threatening for the physician and cannot be handled in a medical context, so the 
patient stays on safe ground by offering physical symptoms (Taylor & Mann, 1999). We need to 
understand more about patients’ beliefs concerning their symptoms, to what causes they attribute 
symptoms, and what treatments they believe are possible. We also need to understand that 
patients may fear that sharing such beliefs lead them to be sent elsewhere, away from the 
medical world.  
Health attitudes and readiness to change  
There has been little emphasis on the measurement of illness beliefs and attributions in 
somatization research, despite the evidence from cognitive psychology that beliefs influence 
behavior (Bandura, 1986). Generally, attributions can either be normalizing (e.g., “I feel ill 
because I’m overworking and unfit”, somatic (e.g., “I feel ill because my system has been 
weakened by a virus”), or psychological (e.g.,  “I feel ill because I’m depressed”) (Burton, 
2003). Studies of primary care patients (Sensky, MacLeod, & Rigby, 1996) and patients with 
high health anxiety (Kirmayer & Robbins, 1996) suggest that normalizing attributions occur less 
often than in controls; furthermore, this lack of normalizing attributions, which might be viewed 
as a form of catastophizing, likely elicits sickness behavior. Others posit that patients appear to 
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have clear views about their symptoms and view their own experience of the symptoms as at 
least as important as a doctor’s opinion about them. Salmon and colleagues suggest that patients 
perceive doctors as denying the validity of the patients’ symptoms when they present with 
medically unexplained symptoms (Peters, Stanley, Rose, & Salmon, 1998), but when doctors 
develop tangible and non-blaming models about the illness, patients are then able to accept 
medical opinion (Salmon, Peters, & Stanley, 1999).  
Attributional styles appear to be rigid and difficult to change, except among patients who 
are young, single, and with short illness duration (García-Campayo, Larrubia, Lobo, Pérez-
Echeverría, & Campos, 1997). Changing specific attributions about symptoms appears to be 
important in effecting improvement. A study by Van Dulmen and colleagues (1996) found that 
when patients with IBS continue to attribute their symptoms to a somatic abnormality even after 
such abnormalities have been ruled out, their use of medical healthcare is likely to increase. 
Also, the physicians’ referral behavior appears to strengthen these dysfunctional somatic 
attributions. These behaviors can be avoided by handling cognitions and anxiety specifically 
during medical consultations in primary care (Van Dulmen, Fennis, Mokkink, & Bleijenberg, 
1996). Changing specific attributions about symptoms appears to be important in effecting 
improvement (Van Dulmen et al., 1996). 
Another dimension to consider in understanding patients’ attitudes and motivations is 
patients’ readiness for change. One of the theories purported to assess readiness and motivation 
to change is the transtheoretical model, which posits that health behavior change involves 
progress through six stages: precontemplation, contemplation, preparation, action, maintenance, 
and termination. Applied research has demonstrated dramatic improvements in recruitment, 
retention, and progress using stage-matched interventions and proactive recruitment procedures 
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(Prochaska & Velicer, 1997). It is important to consider patients’ stage of change in relation to 
their attitudes and beliefs about their symptoms with respect to adopting a psychological rather 
than biological model of symptoms and treatment options. Prochaska and colleagues (2008) 
describe 10 processes of change that are divided into cognitive or experiential processes and 
behavioral processes. The cognitive/experiential processes are best suited for patients in the early 
stages of change, whereas the behavioral processes are best suited for the later stages of change. I 
hypothesize that the majority of patients in the current study will be in the early stages of change 
(i.e., precontemplation and contemplation) in shifting their awareness of the link between their 
stress, psychological conflict, and health; thus, this dissertation will focus on the 
cognitive/experiential processes. The cognitive/experiential processes involve: 1) consciousness 
raising, 2) dramatic relief, 3) self-reevaluation, 4) environmental reevaluation, and 5) self-
liberation. Of particular importance to this dissertation is consciousness raising, which is aimed 
at increasing awareness about the causes and implications of behaviors, and dramatic relief, 
which is aimed at increasing emotional experiences or responses. Based on this theory, it will be 
important for assessments in primary care settings to incorporate increasing awareness of the 
causes and effects of behavior, and focus on increasing emotional experiences. For instance, 
patients with medically unexplained symptoms who insist that they do not have any stress or do 
not acknowledge any links between stress and their physical symptoms may fall into the pre-
contemplation stage. Hence, intervention techniques with these patients would focus on 
psychoeducation and awareness raising to trigger their motivation to change their attitudes. On 
the other hand, patients with MUS who acknowledge the role of stress in perpetuating their 
symptoms would likely benefit from an action-oriented approach like stress management or 
skills training to reduce pain and discomfort.  Hence, it is important to assess patients’ current 
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beliefs and their flexibility and readiness for change in their attitudes and beliefs about their 
symptoms. This approach will help us determine the techniques best suited for their stage of 
change.  
Effectiveness of emotion-focused treatment modalities   
The avoidance of emotions and thoughts may be a common coping strategy among 
individuals dealing with psychosocial distress or interpersonal conflict. This behavior can result 
in distress, helplessness, and physical symptoms, which lead to medical treatment seeking. 
Research suggests that identifying and processing emotions connected to stressful experience, 
conflicts, and secrets can improve pain and other somatic symptoms. In addition, a range of 
evidence supports the view that people will disclose their stressful experiences when asked, and 
that such disclosure, along with emotional expression, will help patients improve their 
symptoms. 
Short-Term Psychodynamic Psychotherapy 
Short-term psychodynamic approaches have been advanced as a way to increase 
emotional awareness and thereby decrease physical symptoms. This approach involves 
examining unconscious motivation, difficulty describing and expressing emotion, and broadly, 
making unconscious phenomena conscious by activating the underlying conflicts the individual 
is facing (Abbass et al., 2009). Abbass (2009) proposes that when emotions become too intense 
or conflicted for an individual, anxiety, as well as defenses against that anxiety, (e.g., 
suppression or avoidance of emotion) occur. Suppressing and avoiding emotions can lead to an 
exacerbation of physical symptoms, and ongoing avoidance serves to maintain those symptoms, 
which is a common process in pain patients. Often, the suppression of emotions and process of 
somatization is unconscious to patients and, therefore, it is important to help the patient develop 
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a greater understanding and experiencing of their emotions (Abbass et al., 2009). To this end, 
research has shown that patients with hypertension, migraine, irritable bowel syndrome, and 
other conditions internalize anger and thus increase their somatic problems (Roter & Ewart, 
1992; Venable, Carlson, & Wilson, 2001). Blocking and inhibiting of emotions, including anger, 
appears to be a common finding in somatizing patients. 
Short-term psychodynamic psychotherapy (STPP) is an intervention that encourages 
patients to acknowledge and engage with avoided emotions and psychological conflicts. A 
systematic review of 23 studies of short-term psychodynamic psychotherapy found generally 
significant and sustained benefits for somatic symptom disorders (Abbass et al., 2009). Short-
term psychodynamic psychotherapy has been shown to reduce healthcare utilization in treating 
patients with MUS, including reductions in total costs, medication costs, disability, hospital, and 
physician use (Abbass, 2003). 
Written Emotional Expression 
Research shows that emotional exposure-based interventions can improve pain symptoms, 
and some studies suggest that expressing rather than avoiding negative emotional experience has 
benefits for reducing pain. For example, writing repeatedly about private stressful experiences 
and avoided emotions (i.e., written emotional disclosure, or expressive writing), has shown 
benefits in controlled studies for a range of populations and outcomes (Frattaroli, 2006; Smyth, 
1998). Written emotional disclosure has been shown to improve immune functioning (Esterling, 
Antoni, Fletcher, Margulies, & Schneiderman, 1994; Petrie, Booth, Pennebaker, Davison, & 
Thomas, 1995), respiratory status (Smyth, Stone, Hurewitz, & Kaell, 1999) and reduce distress 
in women with breast cancer (Stanton et al., 2002). With respect to chronic pain, emotional 
disclosure led to improved health status in patients with rheumatoid arthritis (Smyth et al., 1999), 
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chronic pelvic pain (Norman et al., 2004), and fibromyalgia (Broderick et al., 2005).  
Our laboratory has contributed extensively to this literature, and we have also 
demonstrated that a brief group therapy intervention that enhances anger awareness and 
expression improves chronic headaches (Slavin-Spenny, Lumley, Thakur, Nevedal, & Hijazi, 
2013). Lumley and colleagues (2008) conducted an emotional exposure pilot intervention for 
patients with fibromyalgia and found a moderate to large impact on stress symptoms, symptom 
impact, and emotional distress, and a small to moderate effect on pain and disability at 3-month 
follow-up. Additionally, a study by Hsu and colleagues (2010) showed that an affective self-
awareness intervention improves pain, tenderness, and self-reported physical function for at least 
6 months in women with fibromyalgia compared to waitlist control (Hsu et al., 2010). This study 
suggests the value of interventions targeting emotional processes in fibromyalgia. Collectively, 
these studies suggest that emotional exposure therapies can be effective in improving 
psychological and physical health.  
Diagnostic interviewing  
In 2005, Abbass introduced the notion of emotion-focused interviewing in a healthcare 
setting. He suggested that in order for clinicians to diagnose somatization disorders, they should 
ask about specific recent events to activate emotions and consequent somatic symptoms during 
an emotion-focused interview. Throughout this process, the clinician identifies patterns of 
particular somatic symptoms related to stressful life events, and helps the patient identify and 
recognize them. If a patient has difficulty, Abbass (2005) suggests that a clinician could discuss 
defenses used for emotional avoidance with the patient during their interaction. At the end of the 
interview, findings are reviewed with the patient, in a similar fashion as one would share a 
laboratory finding, such as a blood test. If the interviewer finds that symptoms increase with an 
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emotional focus, and decrease when emotions are not the focus, then the diagnosis is likely 
somatization, and emotion-focused psychotherapy is recommended (Abbass, 2005).  
For an emotion-focused diagnostic interview to be effective, research suggests that the 
patient’s understanding must be considered. Smith and colleagues (2003) have developed a 
multidimensional treatment plan aimed at achieving patient understanding and new ways of 
thinking about somatic symptoms. This plan includes first recognizing that an organic cause was 
not found, rendering further testing and consultation unnecessary. Next is facilitating an 
understanding that their somatic symptoms are real, and that stress, depression and anxiety 
contribute to them. Lastly, patients understand that although medications might help, cure is 
unlikely but improvement is possible. 
Taken together, these various theories, models, and studies suggest that stressful life 
experiences, emotional avoidance, and failure to process negative emotions related to these 
experiences contribute to physical symptoms. To fill a gap in the current literature and enhance 
clinical outcomes for the substantial number of patients in primary care who are so afflicted, 
novel assessment approaches need to be developed. These approaches would aim to both 
influence patients’ understanding of the links between their stress and symptoms and to target 
underlying processes that may improve their physical symptoms.  
Goals of current study 
These various theories and lines of research show that stress and emotional difficulties 
are common in primary care and contribute to physical symptoms, and that people will disclose 
their stressful experiences when asked. The disclosure, along with emotional expression, will 
help patients see the links between emotional processes and symptoms and improve their health. 
Hence, this study tested the feasibility and acceptability of providing an experiential assessment 
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interview that targets emotional and stressful experiences in a primary care setting. I proposed 
that helping an individual first identify the links between their stress and symptoms would 
increase their awareness and endorsement of the link between stress and physical symptoms, 
including a willingness to engage in stress management techniques. Second, I proposed that 
helping raise patients’ awareness about their symptoms, followed by an experience and 
expression of unexpressed emotions would reduce their physical symptoms and psychological 
distress (Figure 1).    
 
 
 
 
Figure 1. Proposed Model 
 
In this study, patients with medically unexplained symptoms were recruited from the 
Crittenton Family Medicine Clinic, randomized to the life-stress interview immediately or to a 
waitlist control condition, and completed baseline and follow-up questionnaires.  
Hypotheses 
The two primary hypotheses regarding patients’ physical health and symptom attributions:  
1. Patients in the life-stress interview group would demonstrate improvements in their 
physical health from baseline to follow-up, compared to those in the waitlist control 
condition. 
2. Patients in the life-stress interview group would demonstrate changes in their 
symptom attributions from baseline to follow-up: 
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a. Patients in the life-stress interview group would score higher on psychological 
attributions, compared to those in the waitlist control condition. 
b. Patients in the life-stress interview group would score lower on somatic 
attributions, compared to those in the waitlist control condition. 
c. Patients in the life-stress interview group would score lower on environmental 
attributions, compared to those in the waitlist control condition. 
Secondary hypotheses regarding patients’ physical status, psychological functioning, and 
motivation for change: 
3. Patients in the life-stress interview group would demonstrate improvements in their 
pain severity and interference, from baseline to follow-up, compared to those in the 
waitlist control condition. 
4. Patients in the life-stress interview group would demonstrate improvements in their 
overall psychological symptoms including depression, anxiety, and interpersonal 
sensitivity from baseline to follow-up, compared to those in the waitlist control 
condition. 
5. Patients in the life-stress interview group would demonstrate improvements in their 
sleep problems from baseline to follow-up, compared to those in the waitlist control 
condition. 
6. Patients in the life-stress interview group would demonstrate improvements in their 
life satisfaction from baseline to follow-up, compared to those in the waitlist control 
condition. 
7. Patients in the life-stress interview group would demonstrate changes in their 
motivation for change from baseline to follow-up: 
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a. Patients in the life-stress interview group would score lower on pre-
contemplation scores, compared to those in the waitlist control condition. 
b.  Patients in the life-stress interview group would score higher on action 
scores, compared to those in the waitlist control condition. No hypotheses 
were specified for contemplation or maintenance scores.  
 Overall, if the hypothesized results are observed, effective stress assessment and 
intervention procedures can be created and integrated in primary care to examine both the 
acceptance of stress-physical symptom connections, and readiness to address stress status among 
patients with elevated physical symptoms. Ultimately, a culture of considering emotional factors 
can be woven into practice, weakening resistance to the idea that emotions and health, mind and 
body, are tightly bound and should be addressed in the primary care setting. 
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CHAPTER 3: METHOD 
Participants 
Participants were 80 men and women who had unexplained somatic symptoms and were 
patients at the Crittenton Family Medicine Clinic in Rochester Hills, Michigan. However, 5 
patients were administratively removed from the study, as described later, resulting in a final 
sample of 75 who were followed and analyzed. All patients endorsed at least a moderate level of 
physical symptoms (>10 on PHQ-15) at screening. Most of the patients (~75%) were recruited in 
the waiting room, about 20% were referred by their primary care physician, and about 5% were 
referred by the psychologist at the clinic. Of 75 patients in the study, 16% had a diagnosis of 
fibromyalgia (n = 12), and 12% had a diagnosis of irritable bowel syndrome (n = 9).  
The majority of patients were women (86.7%); and their mean age was 39.2 years (SD = 
13.66), ranging from 18 to 64 years. Most identified themselves as European American (78.7%), 
whereas 16% identified as African American, 1.3% as Middle Eastern or Arab, and 4% as Other. 
Almost one-third of the participants were never married (30.7%), whereas over one-third were 
either married (24%) or living with their significant other (14.7%). The other participants were 
divorced (26.7%), separated (1.3%) or widowed (2.7%). Participants had a mean education of 
14.0 years (SD = 1.8); that is, slightly over 2 years of college, with 3.8% of the sample with less 
than high school degree, and 28% of the sample with a bachelor’s degree or higher.  
Procedure  
The study was registered on clinicaltrials.gov (NCT02151500). Patients were recruited 
during routine visits either in the waiting room or when referred by their providers. All patients 
were screened using the Patient Health Questionnaire-15 (PHQ-15) (Kroenke et al., 2002), and 
those patients who scored above 10 (moderate range) were contacted by a research assistant to 
  
21
further determine their eligibility, prior to the patient leaving the clinic. The research assistant 
asked patients who scored above the cutoff additional detailed screening questions. Exclusion 
criteria included the presence of disease or injury (e.g., autoimmune disease, bodily injury, 
serious infection, cancer, heart disease, COPD, post-stroke, expecting major medical procedures 
in the next two months) that could account for the elevated physical symptoms, or various 
conditions that could interfere with the interview (non-English speaking, psychosis, dementia, 
mental impairment), or exclusion by the medical staff for other reasons (e.g., presumed drug 
seeking, legal problems). 
Those potential participants who met study criteria and remained interested were invited 
to review the study procedures and provide written, informed consent. Participants received an 
email later that day to complete baseline questionnaires using an on-line system (Qualtrics). 
Questionnaires assessed participants’ health and functioning, psychological distress, life 
satisfaction, and attitudes toward the role of psychological factors in their health. Once they 
completed their baseline questionnaires, participants were contacted by phone, reminded of the 
study requirements, and (assuming their continued interest) randomized into the experimental or 
control conditions. Both the interviewer and patients were blind to condition assignment until 
this time. The randomization scheme was created with randomization.com, prior to recruitment, 
by someone not involved with the patients in the study. Randomization was stratified by 
participant gender and interviewer, occurred in randomized blocks of 3 or 6, and occurred in a 
2:1 ratio (experimental: control); this ratio was used to ensure a larger sample in the 
experimental condition, which would support later analyses of interview content and predictors 
or responses to the interview.  
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Participants randomized to the experimental group were contacted by phone to schedule 
their interview and typically had their interview at the clinic within a week of randomization. Six 
weeks after randomization, all participants received a reminder phone call and a link to complete 
the follow-up questionnaires online. These measures were the same measures that participants 
filled out at baseline; however, reactions to and satisfaction with the interview were added for 
those patients in the interview condition. Participants who were in the waitlist control group also 
completed follow-up questionnaires 6 weeks after randomization. After follow-up, participants in 
the control condition were given the opportunity to participate in the experimental interview. 
Participants received $10 for completing the baseline questionnaires, $20 for completing the 
interview session, and $20 for completing the follow-up questionnaires.  
Emotion-focused Stress Interview  
Two doctoral students in clinical psychology conducted screenings and the interview 
sessions (MZ, n = 31, 65%; HD, n = 16, 35%). Interviewers were trained and supervised by a 
licensed clinical psychologist (MAL) with extensive experience in emotional processing 
interventions. Sessions were audio recorded to facilitate supervision and fidelity checks, as well 
as provide data for secondary analyses of interview content. The interview session was 
conducted in an individualized format, and lasted about 90 minutes in an exam room at the 
clinic. At the beginning and end of the interview session, participants completed a brief measure 
of their mood and symptoms, in addition to their reactions to and satisfaction with the interview. 
Participants’ blood pressure was also measured at the beginning and end of the interview session. 
These latter measures are not included in this dissertation. 
The goals of the interview were to help patients: a) disclose their stressful experiences 
and emotional conflicts, which might be contributing to their symptoms; b) learn about 
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associations between their stress and physical symptoms; and c) learn about the potential value 
of experiencing and expressing their emotions related to these stressful situations. The interview 
occurred in a private room in the clinic and included four phases: 
1. Review of symptoms over life course (≈10 minutes): During the initial phase of the 
interview, participants were interviewed about their medical history, including the onset 
and development of their symptoms over their life course. 
2. Review of life stress and emotional conflict (≈30 minutes): This entailed surveying 
participants’ psychosocial history of stressful life events. The interviewer asked the 
participant about their conflicts over relationships and identified areas of emotional and 
relational conflict for the participant. The interviewer also inquired about other stressful 
events in participants’ lives, including internal struggles and secrets they harbor. At this 
point, the interviewer and patient typically identified a key conflicted interpersonal 
relationship for the patient.  
3. Experiential and expression exercises (≈40 minutes): During the third phase of the 
interview, the interviewer led the participant through a series of emotional experiencing 
and expression exercises, using the study model (Appendix E), which target the two core 
emotional / relational processes that are typically conflicted: dominance (power, agency, 
including anger) and attachment (love, sadness, guilt, and other connecting emotions). 
These exercises encouraged participants to experience affect in their body, and then 
express these emotions in the room, with vocal tone, facial, and physical expression. We 
have used this expression component in several other studies (of fibromyalgia, 
headaches, irritable bowel syndrome), and it is based on the intensive interview 
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successfully used by Abbass (Abbass, 2005) and Dr. Schubiner’s approach to treating 
chronic pain in his clinical practice.  
4. Summary and Discussion (≈10 minutes): Finally, the participants discussed their 
experience with the interviewer, including what they learned about their stress, emotions, 
and links to their symptoms. The interviewer provided feedback of her observations of 
the source and role of stress in the participant’s life, and patients took home a copy of the 
study model discussed during session (Appendix E).   
Control Condition 
After baseline assessment, participants in the control condition engaged only in their 
standard care. After completing the follow-up assessments, these patients were given the 
opportunity to participate in the emotion-focused stress interview.  
Measures (see Appendix B, p. 64) 
There were two primary outcomes; one reflecting change in physical health status, and 
the other reflecting change in attributions about the role of psychological factors in patients’ 
symptoms. 
Somatic symptom severity. The 15-item Patient Health Questionnaire (PHQ-15; Kroenke, 
Spitzer, & Williams, 2002) was used to assess somatic symptoms over the last week. This 
measure is useful in screening for somatization and in monitoring somatic symptom severity in 
clinical practice and research. It contains 15 somatic symptoms or symptom clusters that account 
for more than 90% of the physical complaints reported in the outpatient setting (Van Ravesteijn 
et al., 2009). For each somatic symptom, participants are asked, “During the past week, how 
much have you been bothered by any of the following problems?” The three scoring options are 
coded as 0 (not bothered at all), 1 (bothered a little), or 2 (bothered a lot). Totals of the 15 items 
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are calculated, and scores of 5, 10, and 15 represent cut-points for low, medium, and high 
somatic symptom severity, respectively. The scale demonstrates good test-retest reliability, 
internal validity, and convergent and discriminate validity (Kroenke et al., 2002). This measure 
was used for screening, and as one of the primary outcomes at baseline and follow-up. In this 
sample, the PHQ-15 had relatively low reliability at baseline (α = .59) and adequate reliability at 
follow-up (α = .79). 
Symptom attribution. The Symptom Interpretation Questionnaire (Robbins & Kirmayer, 
1991) was the other primary outcome and assessed somatic, psychological, and normalizing 
causes of somatic symptoms. The SIQ consists of 39 items measuring the degree to which 
participants attribute their symptoms in three areas: psychological (“if I had a prolonged 
headache, I would probably think it was because, I am emotionally upset”), somatic (“if I had a 
prolonged headache, I would probably think it was because there is something wrong with my 
muscles, nerves or brain”), or normal/environmental (“if I had a prolonged headache, I would 
probably think it was because a loud noise, bright light or something else had irritated me”). The 
SIQ yields scores on three subscales corresponding to the three areas of attribution. All items are 
rated on a scale of 0 (not at all) to 3 (a great deal). Higher scores on each subscale indicate 
higher levels of symptom attribution in that area. The scale demonstrates adequate reliability (α's 
for the psychological (13 items), somatic (13 items), and normalizing scales (13 items) were .86, 
.71, and .81, and test–retest correlations over a 4-month period were .63, .60, and .65), 
respectively (Robbins & Kirmayer, 1991). In this sample, SIQ had good reliability at baseline 
(psychological α = .86; somatic α = .84; and normalizing α = .79) and at follow-up 
(psychological α = .91; somatic α = .78; and normalizing α = .86). 
Secondary Outcomes: 
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There were several secondary outcomes reflecting symptom change (physical symptoms, 
psychological functioning) and attitudinal measures assessing motivation for change. 
Pain severity and pain interference. This was assessed using the 16-item Brief Pain 
Inventory (Cleeland & Ryan, 1994). The BPI includes 4 ratings of pain intensity and 12 ratings 
that cover the impact of pain on functioning. Intensity is recorded on a scale from 0 (no pain) to 
10 (pain as bad as you can imagine). Pain is assessed as “current” and as “highest,” “lowest,” and 
“average” during the past week, and calculated by averaging the four pain rating items. Pain 
interference is assessed in terms of how much the patient’s pain interferes with a range of 
activities, on a scale from 0 (no interference) to 10 (interferes completely), and calculated by 
averaging the 12 interference items. The BPI has acceptable psychometric data; coefficient alpha 
of .87 for the four pain intensity items and .91 for the interference scale. In this sample, pain 
severity and pain interference had excellent reliability at baseline (α = .89 and α = .96) 
respectively, and at follow-up (α = .90 and α = .97) respectively. 
Psychological symptoms. This was assessed with the widely used Brief Symptom 
Inventory (Derogatis & Melisaratos, 1983). The BSI consists of 53 items that measure a variety 
of psychological symptoms experienced over the past 7 days. Each item is rated on a scale of 0 
(not at all) to 4 (severely), with higher scores indicating more psychological symptoms. To 
reduce patient burden and focus on constructs relevant to this population, only the depression, 
anxiety, and interpersonal sensitivity subscales were given, which also yield an overall symptom 
severity, resulting in a shortened BSI that is 16 items. This measure has well-established 
reliability, and the subscales being used for this study show adequate internal consistency 
ranging from .74 to .85. In this sample, psychological symptoms scales had good reliability at 
baseline (depression α = .87; anxiety α = .87; and interpersonal sensitivity α = .85; global 
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symptom severity α =. 91); and at follow-up (depression α = .88; anxiety α = .85; and 
interpersonal sensitivity α = .83; global symptom severity α = .93). 
Sleep problems. This was assessed using the 7-item insomnia severity index (Bastien, 
Vallières, & Morin, 2001). The ISI is an index of the global severity of insomnia, including 
perceived daytime consequences and distress. Each item is rated on a 5-point scale from 0 (not at 
all) to 4 (extremely), generating a total score that ranges from 0 to 28 (with higher scores 
indicating more severe insomnia). It has acceptable levels of internal consistency (α = .76 – .78; 
item-total r = .36 – .67) and concurrent validity (Tang, Wright, & Salkovskis, 2007). In this 
sample, this measure had excellent reliability (baseline α = .89; follow-up α = .92). 
Life satisfaction. This was assessed using the 5-item Satisfaction with Life Questionnaire 
(SWLS). The 5-item measure assesses satisfaction with life as a whole. For each item, 
participants rate their satisfaction on a scale from 1 (strongly disagree) to 7 (strongly agree), 
generating a total score that ranges from 5 to 35 (with higher sores indicative of more life 
satisfaction). It shows discriminant validity from emotional well-being measures, good test-retest 
stability and sufficient sensitivity to detect changes (Pavot & Diener, 1993). In this sample, this 
measure had good reliability (baseline α = .86; follow-up α = .89).   
Stage of change. This was assessed by 9 items from the 32-item Change Assessment 
Questionnaire (McConnaughy, Prochaska, & Velicer, 1983), which was done to reduce patient 
burden. Selected items from this questionnaire align with the four stages of change as proposed 
by Prochaska’s transtheoretical stage of change model. Our abbreviated CAQ yields scores on 
four subscales: precontemplation, which is composed of three items (“The best thing I can do is 
find a doctor who can figure out how to get rid of my symptoms once and for all”); 
contemplation, which is composed of three items (“Even if my symptoms don’t go away, I am 
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ready to start changing how I deal with it”); action, which has two items (“I am testing out some 
stress management techniques to manage my symptoms better”); and maintenance, which has 
one item (“I use what I have learned to help keep my symptoms under control”). Items are rated 
on a scale of 0 (strongly disagree) to 4 (strongly agree). Higher scores on each of the subscales 
indicate higher levels of that stage of change. In this sample, CAQ had poor reliability at baseline 
(contemplation α = .61; and action α = .65) and at follow-up (contemplation α  = .57; and action 
α = .77). Reliability for precontemplation was unacceptable both at baseline (α = .31) and 
follow-up (α = .11).  
Statistical Analyses 
After data collection, analyses were conducted in SPSS 22.0. The data were screened 
for missing and out of range values, and frequency distributions of demographic and outcome 
variables were examined for outliers. Data were also examined for non-normal variables by 
examining skewness using histograms. Because variables were not highly skewed, only 
original variables were used in all analyses. Demographic information was analyzed using 
frequency distributions and measures of central tendency. Internal consistency of the outcome 
measures was evaluated using Cronbach’s alpha measure of reliability.  
The success of randomization was determined by comparing the two groups on 
demographics and baseline levels of the outcome measures, using chi-square and t tests. Attrition 
analyses compared study completers to those who did not complete the post treatment 
assessment. An independent-samples t test was used to examine continuous variables. Chi-square 
analyses (including Fisher’s Exact Test) were used to examine categorical variables.   
To test for the effects of the intervention versus control condition on outcomes, intent-to-treat 
(ITT) analyses of the final randomized sample (N = 75) were conducted. ITT analyses were 
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conducted using a multiple imputation procedure in SPSS 22.0 in which each missing outcome 
value was replaced with an imputed value, which takes into account the group condition and 
baseline levels of the outcome measures. Primary analyses of the effects of the interview versus 
control on the outcome measures were conducted, and within-condition paired t tests were 
calculated to asses within-condition changes over time. These were followed by a mixed-design 
(between-within) repeated-measures analyses of variance (RM-ANOVA), assessing between-
condition differences from baseline to follow-up. Significant condition x time interactions 
indicated that the two conditions changed differentially over time. Finally, effect sizes were 
calculated both within and between conditions. Within each condition, d was calculated by 
subtracting the baseline mean from the follow-up mean and dividing by the standard deviation of 
that condition’s baseline mean. The between-condition effect size (dbetween) was calculated using 
the following equation: [(Interview follow-up M – baseline M) – (control follow-up M – baseline 
M)] / SD of the pooled change scores. A negative d within group means that the follow-up score 
was lower than the baseline score, and a negative d between condition effects means that the 
interview group decreased more than the control group did. All significance tests in this study 
used a two-tailed p value of .05, which notably reduces power given the small sample size.  
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CHAPTER 4: RESULTS 
Preliminary Analyses 
 Figure 1 demonstrates participant flow through the study. Eighty participants were 
eligible and interested in participation. These participants were enrolled in the study, completed 
baseline assessments and were randomized. However, 5 participants were administratively 
removed from the study for various reasons, including undergoing surgery after randomization (n 
= 3), drug seeking behavior (n = 1), and criminal charges (n = 1), resulting in a total of 75 
randomized participants. One of the removed patients was randomized into the waitlist group, 
and underwent surgery after randomization, which interfered with follow-up assessment. The 
other 4 patients were randomized into the interview group; two of them underwent surgery 
within the 6 weeks and did not schedule an interview; one patient was discovered to have 
pending criminal charges and medical staff insisted on removing him from the study prior to 
receiving an interview. Finally, the patient who was thought by the staff to be “seeking drugs” 
attended 20 minutes of the interview session, and was no longer interested in participating once 
the goals of the study were reiterated. Hence, these patients were discovered to have not met 
inclusion criteria. 
Baseline Comparisons  
T tests and chi-square tests were conducted to ensure the success of randomization 
between the two groups (Interview, n = 49; Control, n = 26). The two conditions did not differ 
significantly on age, gender, race, marital status, or education (Table 1) or baseline levels of any 
outcome measures (Table 3), suggesting that randomization created equivalent groups on these 
variables. However, there was a statistically significant difference in baseline CAQ maintenance 
for the two conditions (t (73) = -2.12, p = .038, d = 0.53), such that the mean for CAQ 
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maintenance for interview group (M = 2.8, SD = 0.9) was greater than that of control group (M = 
2.3 years, SD = 1.0). Interview group did not differ significantly from the controls on any of the 
other outcome measures at baseline.  
 The majority of participants assigned to the interview group completed the interview, 
except for 2 participants who did not respond to attempts to schedule an interview nor complete 
follow-up assessment. Regarding attrition over the follow-up period, of the 75 randomized 
participants, 8 (10.6%) did not complete follow-up assessments, and were considered “non-
completers” (Interview, n = 6, including the two who did not do the interview; Control, n = 2). 
Completers were defined as those who completed the follow-up assessment at 6 weeks. 
Completers and noncompleters did not differ significantly on most demographic and baseline 
levels of the outcome measures (Table 2). A significant difference was found for baseline BSI 
anxiety (t (73) = -4.43, p < .001, d = 0.97), with completers (M = 1.3, SD = 1.0) having 
significantly higher anxiety than non-completers (M = 0.6, SD = 0.3) at baseline. There was also 
a significant difference between completers and non-completers on SIQ psychological 
attributions (t (73) = -1.99, p = .04, d = 0.85), with completers (M = 1.2, SD = 0.7) more likely 
to endorse psychological attributions for their symptoms than non-completers (M = 0.8, SD = 
0.4) at baseline.  
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Figure 2. Flow Chart of Participants through the Study  
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Table 1 
Comparison of Conditions on Demographic Measures at Baseline 
 
 
 
 
Total 
Sample 
(N = 75) 
 
Interview 
(n = 49) 
Control 
Group 
(n = 26) 
 
t/χ² p  
Age (years) M (SD) 39.2 (13.7) 39.1 (13.7) 39.2 (13.8) 0.03 .97 
Years of 
Education 
M (SD) 14.0 (1.9) 14.08 (2.0) 13.96 (1.6) -0.27  .79 
Gender      0.11 .74 
      Men n (%) 10 (13.3) 7 (14.3) 3 (11.5)   
      Women n (%) 65 (86.7) 42 (85.7) 23 (88.5)   
Ethnicity     0.42 .52 
European 
American 
n (%) 59 (78.7) 37 (75.5) 22 (84.6)   
     African    
     American 
n (%) 12 (16.0) 9 (18.4) 3 (11.6)  
 
 
 
Relationship 
Status 
    2.15 .14 
Partnered n (%) 29 (38.7)  16 (32.7) 13 (50.0)   
     Other n (%) 46 (61.3) 33 (67.3) 13 (50.0)   
       
Note. All tests were two-tailed.   
Chi-square analysis for ethnicity compared European American to African American, due to 
the small numbers in the Other category (n = 4). Chi-square analysis for marital status was 
analyzed comparing Partnered (married or living together with a significant other) to Other 
(single, separated, divorced, widowed), due to the small numbers in the other cells.  
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Table 2.  
Participants Who Completed the Follow-up Assessments Compared to Participants Who 
Were Lost to Follow-up on Demographic and Baseline Levels of the Outcome Measures 
  
Completers 
(n = 67) 
Non-
Completers 
(n = 8) 
 
t/χ² 
 
 
p 
 
d/phi 
Age (years) M (SD)   38.9 (13.8) 41.4 (13.4) 0.48 .63 -0.18 
Education (years) M (SD) 14.1 (1.8)   13.5 (1.9) -0.88 .38 0.32 
Somatic Symptoms M (SD)   12.04 (3.39) 13.13 (5.96) 0.78 .44 -0.22 
Pain Severity M (SD)  4.90 (2.16) 4.69 (2.51) -2.62 .79 0.09 
Pain Interference M (SD)  4.96 (2.64) 5.21 (3.17) 0.24 .81 -0.08 
Depression M (SD)  1.22 (0.94) 1.23 (0.89) 0.02 .98 -0.01 
Anxiety M (SD)  1.33 (1.01) 0.60 (0.31) -4.43 <.01 0.97 
Interpersonal Sensitivity M (SD)  1.37 (1.15) 1.38 (0.09) 0.02 .98 -0.01 
Symptom Severity M (SD)  1.30 (0.85) 1.03 (0.60) -0.86 .39 0.45 
Insomnia Severity M (SD) 16.21 (6.39) 13.13 (7.68) -1.26 .21 0.44 
SIQ Psychological M (SD) 1.24 (0.67) 0.76 (0.44) -1.99 .04 0.85 
SIQ Somatic M (SD) 1.01 (0.62) 0.91 (0.43) -0.43 .67 0.19 
SIQ Environmental M (SD) 1.33 (0.55) 1.03 (0.28) -1.52 .13 0.68 
Life Satisfaction M (SD) 3.34 (1.46) 2.55 (1.30) -1.46 .15 0.57 
CAQ Pre-contemplation M (SD) 2.11 (0.65) 1.63 (0.88) -1.91 .06 0.62 
CAQ Contemplation M (SD) 3.04 (0.69) 2.58 (0.68) -1.79 .08 0.67 
CAQ Action M (SD) 2.29 (0.95) 2.12 (1.09) -0.46 .65 0.17 
CAQ Maintenance M (SD) 2.64 (1.01) 2.88 (0.64) 0.64 .53 -0.28 
Note. All tests were two-tailed. 
Chi-square analysis for marital status was analyzed comparing only Partnered (married or 
living together with a significant other) to Other (single, separated, divorced, widowed), due to 
the small numbers in the other cells. 
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Primary Analyses 
The outcome data for each condition are presented in Table 3; specifically, means and 
standard deviations for each score at baseline and the 6-week follow-up assessment. Regarding 
the primary outcome measure reflecting change in somatic symptoms (assessed with the PHQ-
15), the interview condition had a significant reduction in symptoms from baseline to follow-up, 
showing medium effect size (p = .002, d = -0.49), whereas the control condition showed no 
significant change and a small effect (d = -0.21) over time. However, the conditions did not 
differ significantly in their changes over time (F (1, 73) = 1.69, p = .20, d = -0.32). Regarding the 
primary outcome measures reflecting change in attributions about the role of psychological 
factors in patients’ symptoms, the two conditions did not differ on any of the three symptom 
attributions (measured by SIQ subscales) from baseline to follow-up. Indeed, neither condition 
alone showed a significant change over time on any of the three attributions.  
Changes in pain severity and interference (BPI) were also assessed. The interview group 
experienced reductions in pain severity from baseline to follow-up (p < .001, d = -0.38), whereas 
the control condition showed a small and nonsignificant change (d = .03) over time. There was a 
significant difference between groups on changes in pain severity (F (1, 73) = 6.57, p = .01, d = -
0.67). The interview group also experienced reductions in pain interference from baseline to 
follow-up (p = .001, d = -0.42), whereas the control condition showed small and nonsignificant 
change (d = .19) over time. There was a significant difference between groups on change in pain 
interference over time (F (1, 73) = 10.74, p = .002, d = -0.75). As for insomnia severity (ISI), the 
interview group experienced a decrease in sleep problems from baseline to follow-up (p = .002, d 
= -0.41), whereas the control condition showed no significant change and a small effect (d = 
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0.16) over time. There was a significant difference between the groups on change in sleep 
problems over time (F (1, 73) = 11.10, p = .001, d = -0.75).  
Participants in the interview group improved on some psychological symptoms relative to 
controls from baseline to follow-up. The interview group experienced a reduction in 
psychological symptoms (p = < .001, d = -0.52), whereas the control condition showed no 
change and a minimal effect (d = 0.01) over time. There was a significant difference between the 
groups on changes in psychological symptoms over time (F (1, 73) = 6.56, p = .01, d = -0.60). 
Specifically, the interview group experienced a reduction in BSI Depression (p = .001, d = -
0.43), whereas the control condition showed no change and a small effect (d = 0.05) over time. 
There was a significant difference between the groups on changes in depression scores over time 
(F (1, 73) = 4.93, p = .03, d = -0.51). Changes in BSI Interpersonal Sensitivity were similar. 
Again, the interview group experienced a reduction in interpersonal sensitivity (p = .001, d = -
0.45), whereas the control condition showed no change and a small effect (d = 0.07) over time. 
There was a significant difference between the groups on changes in interpersonal sensitivity 
over time (F (1, 73) = 6.05, p = .02, d = -0.57). Finally, the interview group had a significant 
reduction in BSI Anxiety from baseline to follow-up (p = .001, d = -0.39), whereas the control 
condition showed no change and a small effect (d = -0.09) over time. However, the conditions 
did not differ significantly in their reduction in anxiety over time (F (1, 73) = 2.50, p = .12, d = -
0.39). Finally, the two conditions did not differ on changes in life satisfaction (SWLS) from 
baseline to follow-up.  
Analyses of patients’ motivation for change, as assessed by CAQ, showed a significant 
decrease in CAQ Contemplation scores in the interview condition (p < .01, d = -0.58), whereas 
the control condition showed no significant change and a small effect (d = 0.22) over time. The 
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conditions differed significantly in their change on contemplation scores over time (F (1, 73) = 
9.03, p = .004, d = -0.67). As expected, the interview group showed a significant decrease in 
CAQ Precontemplation scores (p = .02, d = -0.31) and a significant increase in CAQ Action 
scores (p = .001, d = 0.45) from baseline to follow-up, whereas the controls showed no change 
and a small effect on these variables (d = -0.20 and 0.19; respectively) over time. However, 
contrary to expectations, the two groups did not differ significantly in their change over time on 
precontemplation (F (1, 73) = 0.34, p = .56, d = -0.15) or action scores (F (1, 73) = 1.24, p = .28, 
d = 0.16). Given the low reliability of these scales, the results should be interpreted with caution 
and replicated with the full scale.  
Ancillary Analyses 
Data were further explored in a number of ways, using different modes of analyses and 
different subsets of the sample. As an alternative method to RM ANOVA for analyzing the data, 
analyses of covariance were conducted to compare the two conditions on all outcome measures 
(physical symptoms, psychological symptoms, and changes in attributions and motivation) while 
controlling for baseline levels of the outcome measure. The results of these analyses are 
presented in Table 4. This analysis yielded similar results to RM ANOVAs. For instance, pain 
severity, pain interference, interpersonal sensitivity, depression, psychological symptom severity, 
insomnia severity, and CAQ contemplation all remained significantly different between 
interview group and waitlist control group at the 6-week follow-up (p < .05). Anxiety scores (p = 
.009) and CAQ action scores (p = .04) became significantly different between conditions, with 
participants in the interview group demonstrating lower anxiety and higher action scores than 
those in the waitlist group at the 6-week follow-up. As in the initial analyses, the remaining 
outcome measures did not significantly differ between conditions. 
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Second, intent-to-treat analyses were conducted using the baseline value carried forward 
to replace missing values, which assumes no change from baseline, rather than using a multiple 
imputation procedure in which each missing outcome value was replaced with an imputed value 
calculated using a multiple imputation procedure in SPSS 22.0. This analysis did not alter the 
significant findings from the primary analyses noted above, conducted with RM ANOVA, except 
for depression and interpersonal sensitivity, which became nonsignificant at the 6-week follow-
up, p = .08 (partial eta2 = 0.07) and p = .06 (partial eta2 = 0.08), respectively. Third, RM 
ANOVAs were conducted only on the sample of 67 completers (Interview n = 43; Control n = 
24; Total sample N = 67), and results did not differ from analyzing the results with the Total 
sample (N = 75) described above (with the multiple imputation technique).  
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Table 3. 
Within and Between-Condition Comparisons of Outcomes from Baseline to 6-week Follow-up 
 
Outcome Measure  
Interview Condition 
(n = 49)  
Waitlist Condition 
(n = 26) 
Condition x Time 
Interaction 
 M (SD) dwithin M (SD) dwithin F (1,73) p dbetween 
Somatic Symptoms         
  Baseline  12.18 (3.88)  12.19 (3.45)     
  6 weeks 10.28 (5.30)  11.48 (3.58)     
  Change Score  -1.89 (4.13) -0.49** -0.71 (2.89) -0.21 1.69 .20 -0.32 
SIQ Psychological        
  Baseline 1.15 (0.61)  1.27 (0.75)     
  6 weeks 1.05 (0.72)  1.28 (0.58)     
  Change Score  -0.09 (0.74) -0.16 0.01 (0.49) 0.01 0.67 .42 -0.20 
SIQ Somatic        
  Baseline  0.97 (0.58)  1.06 (0.64)     
  6 weeks  0.91 (0.51)  1.02 (0.48)     
  Change Score  -0.06 (0.49) -0.10 -0.04 (0.45) -0.06 0.03 .86 -0.04 
SIQ Environmental         
  Baseline  1.26 (0.54)  1.37 (0.54)     
  6 weeks 1.23 (0.51)  1.38 (0.63)     
  Change Score  -0.03 (0.54) -0.06 0.01 (0.52) 0.02 0.11 .74 -0.08 
Pain Severity        
  Baseline  4.91 (2.17)  4.83 (2.24)     
  6 weeks 4.08 (2.45)  4.88 (1.90)     
  Change Score  -0.83 (1.26) -0.38*** 0.04 (1.29) 0.03 6.57 .01 -0.67 
Pain Interference         
  Baseline  5.23 (2.81)  4.55 (2.39)     
  6 weeks 4.05 (2.94)  5.01 (2.81)     
  Change Score  -1.18 (2.25) -0.42** 0.45 (1.63) 0.19 10.74 .002 -0.75 
Sleep Problems         
  Baseline  16.04 (5.95)  15.58 (7.69)     
  6 weeks  13.62 (7.57)  16.81 (6.82)     
  Change Score  -2.42 (5.08) -0.41** 1.23 (3.20) 0.16 11.09 .001 -0.75 
Depressive Symptoms        
  Baseline  1.26 (0.90)  1.15 (0.99)     
  6 weeks 0.86 (0.92)  1.19 (0.82)     
  Change Score  -0.41 (0.79) -0.43** 0.05 (0.95) 0.05 4.93 .03 -0.51 
Anxiety Symptoms        
  Baseline  1.18 (1.01)  1.40 (0.94)     
  6 weeks 0.79 (0.82)  1.31 (0.77)     
  Change Score  -0.38 (0.76) -0.39** -0.09 (0.74) -0.09 2.50 .12 -0.39 
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Interpersonal 
Sensitivity  
  Baseline  1.42 (1.12)  1.26 (1.16)     
  6 weeks  0.92 (0.96)  1.34 (0.92)     
  Change Score  -0.50 (0.99) -0.45** 0.09 (0.95) 0.07 6.05 .02 -0.57 
Psychological 
Symptoms  
       
  Baseline 1.27 (0.83)  1.27 (0.85)     
  6 weeks  0.84 (0.82)  1.28 (0.69)     
  Change Score  -0.43 (0.68) -0.52*** 0.01 (0.75) 0.01 6.56 .01 -0.60 
Life Satisfaction        
  Baseline  3.21 (1.45)  3.34 (1.49)     
  6 weeks  3.51 (1.57)  3.39 (1.37)     
  Change Score  0.29 (1.16) 0.21 0.05 (0.96) 0.03 0.88 .35 0.22 
CAQ Pre-
contemplation  
       
  Baseline 2.03 (0.71)  2.10 (0.65)     
  6 weeks 1.81 (0.61)  1.97 (0.53)     
  Change Score  -0.22 (0.64) -0.31* -0.13 (0.58) -0.20 0.34 .56 -0.15 
CAQ Contemplation        
  Baseline  3.07 (0.71)  2.85 (0.67)     
  6 weeks 2.66 (0.68)  3.00 (0.68)     
  Change Score  -0.41 (0.86) -0.58** 0.16 (0.62) 0.22 9.03 .004 -0.67 
CAQ Action        
  Baseline  2.32(0.98)  2.19 (0.96)     
  6 weeks  2.76 (0.77)  2.37 (0.78)     
  Change Score  0.45 (0.95) 0.45** 0.18 (1.04) 0.19 1.24 .27 0.28 
CAQ Maintenance         
  Baseline  2.84 (0.94)  2.35 (0.96)     
  6 weeks  2.81 (0.83)  2.49 (0.95)     
  Change Score  -0.02 (1.07) -0.03 0.14 (1.04) 0.14 0.43 .51 -0.15 
d-within is the within-condition effect size ((post M – baseline M) / baseline SD). 
d-between is the between-condition effect size ((Interview follow-up M – baseline M) – (control 
follow-up M – baseline M)) / SD of the pooled change scores. 
* p < .05, ** p < .01,  *** p < .001 (two-tailed paired-samples t test within each group) 
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Table 4.  
Results of Analyses of Covariance at Baseline and Follow-up, comparing Condition Group Adjusted 
Means, Covarying for Baseline Values of Outcomes  
 
Outcome Measure 
 
Time Point 
Interview 
Group 
(n = 49) 
Control 
Group 
(n = 26) 
 
F(df) 
 
p 
 
Partial Eta-
squared 
Physical Symptoms Baseline M (SD)  12.18 (3.88) 12.19 (3.45)    
 6-week M (SD) 10.28 (5.30) 11.48 (3.58)    
 6-wk Adj. M (SE) 10.29 (0.53) 11.47 (0.73) 1.74 0.19 0.02 
SIQ Psychological Baseline M (SD)  1.15 (0.61) 1.27 (0.75)    
 6-week M (SD) 1.05 (0.72) 1.28 (0.58)    
 6-wk Adj. M (SE) 1.08 (0.07) 1.23 (0.10) 1.39 .24 0.02 
SIQ Somatic Baseline M (SD)  0.97 (0.58) 1.06 (0.64)    
 6-week M (SD) 0.91 (0.51) 1.02 (0.48)    
 6-wk Adj. M (SE) 0.93 (0.05) 0.98 (0.07) 0.45 .51 0.01 
SIQ Environmental  Baseline M (SD)  1.26 (0.54) 1.37 (0.54)    
 6-week M (SD) 1.23 (0.51) 1.38 (0.63)    
 6-wk Adj. M (SE) 1.25 (0.07) 1.34 (0.09) 0.65 .42 0.01  
Pain Severity  Baseline M (SD)  4.91 (2.17) 4.82 (2.24)    
 6-week M (SD) 4.08 (2.45) 4.88 (1.90)    
 6-wk Adj. M (SE) 4.06 (0.18) 4.83 (0.25) 6.61 0.01 0.08 
Pain Interference  Baseline M (SD)  5.23 (2.81) 4.55 (2.39)    
 6-week M (SD) 4.05 (2.94) 5.01 (2.81)    
 6-wk Adj. M (SE) 3.86 (0.28) 5.36 (0.39) 9.42 .003 0.12 
Sleep Problems Baseline M (SD)  16.04 (5.95) 15.58 (7.69)    
 6-week M (SD) 13.62 (7.57) 16.81 (6.82)    
 6-wk Adj. M (SE) 13.48 (0.64) 17.08 (0.88) 10.93 .001 0.132 
Depression Baseline M (SD)  1.26 (0.90) 1.15 (0.99)    
 6-week M (SD) 0.86 (0.92) 1.19 (0.82)    
 6-wk Adj. M (SE) 0.83 (0.11) 1.24 (0.14) 5.11 .03 0.07 
Anxiety Baseline M (SD)  1.18 (1.01) 1.40 (0.94)    
 6-week M (SD) 0.79 (0.82) 1.31 (0.77)    
 6-wk Adj. M (SE) 0.83 (0.08) 1.23 (0.12) 7.11 .009 0.09 
Interpersonal sensitivity  Baseline M (SD)  1.42 (1.12) 1.26 (1.16)    
 6-week M (SD) 0.92 (0.96) 1.34 (0.92)    
 6-wk Adj. M (SE) 0.89 (0.11) 1.39 (0.15) 6.87 .01 0.08 
Psychological Symptoms  Baseline M (SD)  1.27 (0.83) 1.27 (0.85)    
 6-week M (SD) 0.84 (0.82) 1.28 (0.69)    
 6-wk Adj. M (SE) 0.84 (0.09) 1.28 (0.12) 8.68 .004 0.11 
Life Satisfaction Baseline M (SD)  3.21 (1.45) 3.34 (1.49)    
 6-week M (SD) 3.51 (1.57) 3.39 (1.37)    
 6-wk Adj. M (SE) 3.54 (0.15) 3.23 (0.20) 0.75 .39 0.01 
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CAQ Pre-contemplation  Baseline M (SD)  2.03 (0.71) 2.10 (0.65)    
 6-week M (SD) 1.81 (0.61) 1.97 (0.53)    
 6-wk Adj. M (SE) 1.82 (0.07) 1.95 (0.09) 1.08 .30 0.02 
CAQ Contemplation Baseline M (SD)  3.07 (0.71) 2.85 (0.67)    
 6-week M (SD) 2.66 (0.68) 3.00 (0.68)    
 6-wk Adj. M (SE) 2.63 (0.09) 3.06 (0.13) 7.14 .009 0.09 
CAQ Action Baseline M (SD)  2.32(0.98) 2.19 (0.96)    
 6-week M (SD) 2.76 (0.77) 2.37 (0.78)    
 6-wk Adj. M (SE) 2.75 (0.10) 2.39 (0.14) 4.08 .04 0.05 
CAQ Maintenance  Baseline M (SD)  2.84 (0.94) 2.35 (0.96)    
 6-week M (SD) 2.81 (0.83) 2.49 (0.95)    
 6-wk Adj. M (SE) 2.76 (0.12) 2.59 (0.17) 0.73 .39 0.01 
Note. All tests were two-tailed.  
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CHAPTER 5: DISCUSSION 
In this study, the 90-min interview session sought to help patients identify and endorse 
links between their emotional stress and their physical symptoms. It also sought to engage 
patients in an exercise to enhance emotional awareness, experiencing, and expression, with the 
goal of reducing their physical symptoms and psychological distress. Although the first goals 
may not have been achieved, the second was. 
 This trial has several key findings. First, the interview was effective in reducing pain 
severity, pain interference, depression, interpersonal sensitivity, and psychological symptoms, in 
addition to improving sleep problems after 6 weeks, compared to standard care without the 
interview, among primary care patients with medically unexplained symptoms. This finding 
suggests that an emotional processing approach has the potential to be a viable technique for 
targeting pain and psychological symptoms among patients with medically unexplained 
symptoms. The finding that the interview led to significantly greater reductions in pain severity 
and interference after 6 weeks, compared to controls, is notable, because it suggests that that 
emotional awareness and expression training is effective in reducing pain, which is considered 
the hallmark of medically unexplained syndromes. It may be that a technique that helps people 
confront rather than avoid emotionally laden experiences, better targets core factors (e.g., 
emotional avoidance, failure to process and resolve stress) that are responsible for maintaining 
and prolonging stress-related symptoms. This interpretation is in line with research that has 
demonstrated a relationship between stressful life events and pain symptom exacerbation 
(Abbass et al., 2009; Burger et al., 2016; Hsu et al., 2010; Lampe et al., 2003; Slavin-Spenny et 
al., 2013).  
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Second, the interview was effective at improving depression, interpersonal sensitivity, 
and general psychological symptom severity from baseline to 6-week follow-up, as compared to 
the waitlist control. Similarly, the interview was also effective at improving sleep problems from 
baseline to follow-up. Our experiential exercise is thought to target avoidance of negative 
emotional experiences and facilitate the processing of unresolved stress. Previous research has 
shown that emotional expression can directly target psychological symptoms by helping to 
regulate internal states (Ekman & Davidson, 1993), which is associated with reduced 
interpersonal sensitivity and increased prosocial behavior (Lopes, Salovey, Côté, Beers, & Petty, 
2005) as people are more able to make balanced appraisals of their environment. This pattern of 
findings is aligned with research suggesting that treatments that target pain patients' emotional 
complexity can influence social information processing as well (Davis, Zautra, & Smith, 2004). 
As such, an approach that enhances emotional skills may increase the ability of those with 
chronic pain conditions to preserve positive engagement during their experience of pain (Zautra, 
2006).  
In addition, in terms of motivation for change, the interview had an effect on 
contemplation thinking, but no effect between the two groups on precontemplative and action-
oriented thinking. However, patients in the interview group reported reductions in 
precontemplative and contemplative thinking, and a significant increase in action oriented 
perspectives from baseline to follow-up. Decreases in precontemplation and contemplation 
thoughts about readiness for change are congruent with expected effects of the intervention, 
because it suggests that patients are no longer “wondering” about their readiness to change and 
might have already initiated the change process. In addition, increases in action thinking are also 
aligned with expectations as patients are shifting toward a new approach for managing their 
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condition. It is likely that patients entered the study contemplating change, between 
precontemplation and contemplation, and shifted toward action-based perspectives 6 weeks later, 
as reflected by increases in action scores. 
Third, although the interview did not affect somatic symptoms, patients in the interview 
group experienced significant reductions with a medium effect in somatic symptoms over time, 
whereas the control group had a meaningfully smaller effect. It is notable that PHQ-15 was used 
both as a screening and change measure in this study, even though PHQ-15 has been developed 
and validated as a screening tool (Kroenke et al., 2002). Other investigations by the developers 
ascertained the PHQ-15 as a well-validated measure for detecting and monitoring somatization 
(Kroenke et al., 2010) with no mention of its use as an outcome measure. More importantly, in 
an intervention study for MUS, researchers have used PHQ-15 to determine symptom severity at 
baseline, but their primary measure of change was Clinical Global Impression (CGI) rating of 
severity of physical symptoms (CGI-severity) and the CGI rating of improvement of physical 
symptoms (CGI-improvement) (Escobar et al., 2007), following methods done by Allen and 
colleagues (Allen, Woolfolk, Escobar, Gara, & Hamer, 2006). Hence, it appears that PHQ-15 is a 
well-validated screening tool, and similar to other general physical symptom checklists, it may 
not reflect change very well. Finally, the CAQ subscales and PHQ-15 had low reliability, which 
likely affected their validity as a change measures.   
Contrary to expectations, there were no changes on primary measures of change in 
symptom attributions about the role of psychological factors in patients’ symptoms. These 
findings were surprising, as the intervention purported to raise the patient’s awareness about the 
role of stress and emotional factors in the manifestation and exacerbation of their physical 
symptoms. It is notable that the SIQ has not been tested for its use as a change measure, and it is 
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possible that attributions assessed by it are not readily changed. Other studies of SIQ have not 
used it as a change measure, and generally categorize participants based on their attributional 
style into psychologisers, somatisers, and normalisers. For example, one study of Gulf War 
veterans demonstrated associations between these three attributional styles and patterns of 
symptom reporting, and found that psychologising was associated with higher symptom 
reporting, whereas somatisers and mixed-attribution also demonstrated higher reporting than 
normalisers (Wright, McFarlane, Clarke, Sim, & Kelsall, 2015). Research has also tested the 
ability of attributional styles to predict psychiatric conditions, namely depression and anxiety 
(Kessler, Heath, Lloyd, Lewis, & Gray, 1999), suggesting that the SIQ may be tapping into more 
stable trait-like constructs that are associated with symptom endorsement and psychological 
functioning. Research also shows distinguishable attributional patterns between patients with 
somatoform disorder and those with chronic pain (Hiller et al., 2010), and perhaps the 
heterogeneous nature of our sample made it difficult to identify distinct attributional patterns and 
changes over time. In addition, perhaps attributional styles should have been conceptualized as 
distinct predictors of change in symptom endorsement instead of mutable attitudes.   
 In addition, given the complexity of medically unexplained syndromes, the patients 
might have had a more comprehensive or multi-causal understanding of their symptoms. For 
instance, patients with chronic headaches may recognize the role of psychological variables in 
initiating or maintaining their headaches, but also believe that organic causes underlie their 
vulnerability to developing headaches, and environmental factors (e.g., light) can exacerbate 
their symptoms. Finally, given the sample’s range of health problems, some of the conditions 
may have had a more primary organic cause versus conditions that may be more stress-driven. 
For example, research shows that headaches have a neurological basis, and they are likely 
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initiated by one of numerous pathways including nerve stimulation, irritation or disinhibition 
(Bogduk et al., 2000). This might influence patients’ attributions regarding the etiology of their 
conditions, and render it rather challenging to reliably assess changes in attributions across a 
wide range of conditions of complex etiology and diverse presentation.  
Finally, the groups did not differ on life satisfaction over time. It is possible that 
emotional awareness and expression training may be an effective approach for reducing negative 
emotions and accompanying physical symptoms, but not as effective at improving overall 
positive affective states like life satisfaction. The null findings on the life satisfaction measure 
may be due to a number of factors. Improving life satisfaction may take longer, require a larger 
improvement in psychological functioning, or require an intervention designed to enhance 
satisfaction, which is conceptually different from targeting affect. The SWLS scale assesses 
global life satisfaction, which by definition is not circumscribed to one domain such as physical 
health, and hence it might not be affected by change in that domain. Research on the relationship 
between cognitive-judgmental aspect of subjective well-being (life satisfaction) and hedonic 
balance (affectivity) is mixed. Some studies show a relationship between improved depression 
and improved quality of life (Ruo et al., 2003), whereas other studies suggest that among 
recovering depressed patients, quality of life remains lower than that among non-depressed 
patients (Dan & Younossi, 2010). Hence, it is possible that improving psychological functioning 
does not majorly affect the global appraisal of a person’s life, which includes family, job, 
achievements, and other joys and regrets.  
Clinical observations of the interviewers support study findings, and suggest that the 
interview session was an effective and important experience for study participants. Although 
formal content analyses were not conducted, some interview observations are noted in this 
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section. On average, interview sessions lasted for 90 minutes (SD = 6.8), and ranged in content, 
depending on the nature of patients’ trauma and conflict. For example, some patients identified 
sexual abuse or rape experiences as their stressful event, whereas others identified relational 
conflict, such as strained relationships with parents and sibling, or marital conflict, as their 
primary stressor. Interview sessions also ranged in intensity and resulted in variable patient 
responses. This variability was related to several factors, including patients’ level of engagement 
and the nature of their conflict. For example, some patients became fully engaged and expressed 
intense emotion (e.g., anger) toward perpetrators and enacted adaptive aggression that had been 
suppressed. Other patients experienced difficulty identifying and expressing emotion, and the 
emotional awareness and expression components were new to them, whereas others expressed 
previously avoided emotions (e.g., expressing love or need for a parent with whom they are in 
conflict). The session served as a novel opportunity to disclose stressful experiences, become 
aware of emotions, and express emotions that may have been previously avoided.  
Overall, patients expressed a range of positive reactions to the interview, including 
newfound awareness, surprise, appreciation, and relief. Many patients appreciated learning about 
the links between their stress and physical symptoms, and for a subset of patients, this was a new 
and “eye-opening” model of understanding their symptoms. Patients also noted that they were 
surprised by their emotional experience and did not realize they were holding on to certain 
emotions, as one patient noted that she “did not realize [she] was harboring all this anger” toward 
her neglectful father. Most patients felt validated by this experience, and noted both in session 
and at the 6-week follow-up that the therapists were validating and sensitive to their experiences. 
Many patients experienced intense emotions during the experiential exercise, but often times 
expressed relief at the end of the exercise. For example, one patient expressed anger and then 
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sympathy toward her mother, who intimidates her badly. The patient expressed excitement about 
the relief that she felt during the interview and the reduction in her symptoms. The symptom 
relief following the experiential session was a pivotal moment that the therapists highlighted to 
patients to illustrate the immediate effects of expressing previously avoided and important 
emotion.  
Finally, follow-up qualitative reports by patients showed that patients were appreciative 
of the interview experience. Patients noted changes in their understanding of their symptoms. For 
example, one patient wrote, “glad to now understand how much my emotional stress triggers my 
painful symptoms, it happened before our eyes during the interview after I cried so that opened 
my eyes up to things. Need to work on getting over past. Only negative thing wish I had more 
time!” Similarly, another participant concluded, “I realized a lot of physical pain can be linked to 
how you are feeling emotionally. In order for some of the physical pain to go away you have to 
resolve the emotional problems. When I met with the interviewer she brought up events in my 
life I needed to deal with it and I have. I feel a lot better emotionally and physically.” Patients 
also expressed a need to seek mental health services. For example, “I believe I need more intense 
mental health care.” Others patients noted learning more about themselves and their personality 
attributes; for example, “I learned I am good at anger and not communication.”  
Study Strengths and Limitations  
This study has many strengths and a number of limitations. First, participant attrition was 
fairly low and intervention sessions were well attended, as only two participants randomized to 
the interview group did not schedule an interview. In addition, participants were followed 6 
weeks post-randomization so benefits could be assessed over time. It is also important to note 
that participants were recruited from primary care and not a tertiary specialty clinic. This means 
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that the sample consists of patients who are not typically engaged in psychotherapy and have 
likely not disclosed or processed the issues that they are bringing. Patients in psychological care, 
and often in special medical care, have heightened distress and perhaps more experience with 
mental health providers, possibly leaving them less likely to respond positively to this 
intervention. In addition, the current sample is likely quite generalizable, given the high 
prevalence of these conditions in primary care. This sample likely represents the wide range of 
people who are characterized as having medically unexplained symptoms in the community, 
given that some are treatment seeking for their symptoms, and others were seeking treatment for 
other reasons and simply met criteria on our screening measure.  
Another strength of this study is the range of measures, which captured physical and 
psychological symptoms, in addition to changes in attributions about the role of psychological 
factors in patients’ symptoms and motivations for change. However, data were primarily 
collected by self-report, which can be problematic. Participants may not be able to accurately 
recall their experiences over time, which may have biased these findings. Participants may try to 
respond favorably, in which case social desirability may have biased our findings. Other types of 
assessments (e.g., symptom diaries, physician-rated measures, biological measures) can provide 
more accurate or objective information. Another strength of this study is that it used a 
comparison waitlist control condition, which controlled for many threats of internal validity (e.g., 
maturation, history, statistical regression to the mean). However, a waitlist did not control for 
nonspecific aspects of the interview (e.g., attention, support). A credible placebo control (e.g., 
relaxation training) would have helped to determine whether or not nonspecific factors 
influenced treatment outcomes.  
Some study limitations include a highly heterogeneous study sample, recruited via 
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different methods (i.e., some were recruited in the waiting room by research staff, or a referral by 
a physician or a clinic psychologist). Referrals by a clinic psychologist may have contributed to 
sampling bias, however, only a small percentage of the patients were recruited by this method. In 
addition, the relevance of effects to treatment-seeking patients versus non-treatment seeking 
individuals could not be determined. An important limitation is a limited statistical power due to 
a modest sample size and the imbalanced cell size in the two conditions, which was adopted to 
maximize interview patients for secondary analyses. The low power limits the ability to interpret 
null findings, but in this sample the groups provided sufficient power to detect medium effects 
but were underpowered to detect meaningful changes in the small-to-medium range. The sample 
also included many more women (87%) than men. Although the distribution reflects the 
population of medically unexplained conditions in general (Nimnuan, Hotopf, & Wessely, 2001) 
and of those in primary care specifically, these findings will not necessarily generalize to men 
with these symptoms/conditions. It is notable that the study did not have sufficiently-sized 
subgroups to explore potential differences between European American and African American 
participants. Only 4 participants belonged to other racial groups, which further limits 
generalizability of findings. Research exploring health and emotion across race has shown 
different patterns of psychopathology, including comparative rates of anxiety disorders (Brown, 
Shear, Schulberg, & Madonia, 1999), and different depressive responses (Blazer, Landerman, 
Hays, Simonsick, & Saunders, 1998; Decoster, 2003). This suggests that African Americans may 
have different emotional response patterns that would be important to study. 
Next, some of the study measures had poor reliability in this sample. For example, the 
PHQ-15 had poor internal consistency at baseline, but good internal consistency at the 6-week 
follow-up. The poor value seen at baseline is much lower than previous studies, which have 
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reported at least acceptable internal consistency (e.g., α range = 0.79- 0.89) (Interian, Allen, 
Gara, Escobar, & Díaz-Martínez, 2006; Kroenke et al., 2002). It is also unclear why internal 
consistency was lower at baseline and increased over time. Possible explanations may include 
the heterogeneity of the sample, and patients may have not endorsed items consistently due to the 
varying nature of their conditions and their pain experience, suggesting that lower consistency 
values can be expected given the diversity of constructs measured. Alternatively, patients may 
have provided more thoughtful and consistent responses after participating in the interview, 
resulting in improved reliability. In addition, in this study, we did not use the original CAQ 
measure and selected 9 relevant items to reduce patient burn, which likely led to the 
unacceptable to poor baseline reliability (α range= .31 - .65), and unacceptable to acceptable 
follow-up reliability (α range = .11 - .77). This low reliability is likely due to a number of 
factors, including a small and inconsistent number of items on the subscales. For example, CAQ 
maintenance was made of one item “I use what I have learned to help keep my symptoms under 
control”, limiting its validity and reliability in measuring what it purports to measure. Future 
studies should use the complete 32-item CAQ measure with established validity and reliability 
(CAQ; McConnaughy, Prochaska, & Velicer, 1983). 
Finally, treatment fidelity, defined as the strategies that monitor and enhance the accuracy 
and consistency of an intervention, was not formally assessed. However, to offset this limitation, 
interviews were audio recorded, and some were listened to for supervisory purposes. Also, there 
was a learning curve for therapists, given the complexity of the interview, which involved 
various domains (e.g. medical history, stress history, emotional processing and experiencing), 
and required some degree of flexibility to tailor it to the individual needs of each participant. 
However, both therapists received weekly supervision by a licensed clinical psychologist who 
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has expertise in stress, emotional processes, and emotional exposure approaches to intervention. 
Supervision was group-based and involved didactics, a review of audiotaped samples, and 
extensive feedback. All of these efforts likely improved knowledge, competence, and adherence 
of the therapists. 
Clinical observations shed some light into study limitations. Overall, patients’ 
engagement in the interview varied. Individual differences may account for the level of patients’ 
engagement in the intervention, and hence the expected benefit. It appears that for a subset of 
patients who were unaware of avoided emotional experiences, satisfied with their current 
relationships, or otherwise not motivated for change, they appeared to have the least success with 
the interview. It is also important to note that a minority of patients lacked insight or did not 
understand the treatment rationale, and hence had difficulty engaging with the interview. In 
addition, some participants who generally had an avoidant style tended to deny any emotional 
conflict and had difficulty with the emotional experiencing exercises. For example, one 
participant endorsed childhood physical and emotional abuse by his parents but did not 
acknowledge that he might currently have conflicted feelings toward his parents that he wants to 
process, “it’s all behind me,” he explained. Others commented that it was hard to reconnect with 
their buried anger and found the session exercise challenging; “I’m not angry now, and it’s hard 
for me to pretend that I am.” Clinical observations suggest that a subset of patients found the 
interview unconventional, and often times noted that it was not what they were expecting. More 
research is needed to determine what patient characteristics are associated with patient outcomes 
for this population, and how to best target these in treatment. 
Clinical implications  
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The study has important clinical implications. First, it demonstrates the feasibility of 
implementing this interview in a primary care setting with patients who have medically 
unexplained conditions. Second, study results show that one interview session is effective in 
helping patients reduce their physical symptoms and improve their psychological functioning, 
with no evidence of harmful effects. Third, the study demonstrates how current medical practices 
are missing this entire realm of psychological functioning and contributors to poor health, which 
needs attention. It appears that a single emotional awareness and expression interview, conducted 
in the primary care setting, is a viable technique to improve symptoms, as well as shift readiness 
and motivation for seeking psychologically-oriented treatment.  
In addition, research on psychological interventions for medically unexplained symptoms 
has focused primarily on cognitive and behavioral approaches to intervention (Nezu, Nezu, & 
Lombardo, 2001), and more recently, mindfulness-based cognitive therapy (Van Ravesteijn et 
al., 2014) which seek to decrease arousal and manage symptoms. This is the first study to 
systematically assess a brief one-session intervention targeting emotional awareness and 
expression for primary care patients with medically unexplained symptoms, and the study has 
encouraging results. Thus, an emotion-focused approach may be a useful technique for people 
with MUS for a number of reasons. First, it is brief, requiring participants to attend as little as 
one session. Next, it is effective in reducing pain symptoms, which is a hallmark of MUS. It also 
teaches patients to experience and express emotions, which has the potential to not only improve 
health and functioning, but also is likely to enhance interpersonal communication and help 
individuals to develop and maintain more meaningful relationships.  
Future Directions  
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It is important to replicate this study using a larger sample that is informed by a power 
analysis to ensure reliability of the findings. Such a study should also include additional health 
outcomes that may be affected by these interventions. For example, one might include measures 
examining assertiveness levels, interpersonal functioning, and healthcare utilization. It is also 
unclear exactly how emotional awareness and expression training operates relative to cognitive-
behavioral approaches. In order to enhance understanding of the active ingredients of change, 
process research examining potential mediators (e.g., self-efficacy, resolved stress symptoms, 
decreased physiological arousal, mastery, insight) needs to be conducted. In addition, given the 
heterogeneity of MUS, it is likely only a subgroup of patients will benefit from any single 
treatment approach. Therefore, future research should examine patient characteristics that may 
be potential moderators of treatment outcomes, such as baseline assertiveness, ambivalence over 
emotional expression, and emotional processing abilities. This can help better direct clinical care 
by tailoring treatment to the needs of different individuals. Such studies might also include 
measures of nonspecific factors, or homework adherence, to determine if these factors might 
account for the data.  
In addition, only a one-session “dosage” of treatment was tested; however, it is possible 
that a longer intervention (e.g. 3-5 sessions) would result in stronger effects. One session is likely 
not enough for participants to enhance their emotional awareness, release inhibited affect, and 
successfully resolve emotional conflicts. Therefore, researchers should consider testing a longer 
version of this intervention to identify the most beneficial length of treatment. Also, readiness to 
change might be conceptualized and tested as a moderator instead of an outcome measure. In 
addition, it is also important to consider the possibility that a participant may have more than one 
emotional conflict that needs to be addressed. For example, in this study one participant noted 
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that she was verbally and physically abused by her adoptive parents, and also raped by a stranger 
as an adult. These two scenarios brought up different sources of conflict for her that needed to be 
addressed. In this case, multiple sessions might be needed to resolve the patient's underlying 
issues. However, adding additional treatment visits may enhance participant burden and/or 
increase the chance of attrition. To meet the needs of the participants, researchers could consider 
adding a booster session 1 month after final treatment session to help the participant continue to 
work through issues that linger.   
It is also important examine the impact of these interventions in different samples. Many 
patients with MUS do not seek medical treatment, or they stop consulting with medical providers 
because current treatments are often unhelpful. Some argue that these medically unexplained 
syndromes are all related (Yunus, 2008). It may be advantageous to discern if patients who have 
one condition (e.g., IBS) would respond differently than patients with comorbid conditions, or 
whether a longer dose of the intervention might be needed for patients with comorbid conditions. 
It might also be informative to test how these effects differ when tested in a different setting, 
including specialty clinics, where patients are highly distressed. 
Although the focus of this study was on piloting a novel one-session interview for MUS 
in primary care, it is worth considering how this technique may work in conjunction with other 
established approaches that are already used in these settings. There is a movement towards more 
integrated, multicomponent treatment packages in research and practice. A similar approach 
could be used for this population. For example, a recent multicenter, randomized, active-
controlled study compared the efficacy of a CBT enriched with an emotion regulation training 
(ENCERT) with a conventional CBT for MUS (Kleinstäuber, Gottschalk, Berking, Rau, & Rief, 
2016). Study findings showed that the combination is more efficacious than traditional cognitive 
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behavior approaches in patients with MUS, and concluded that enriching CBT with 
transdiagnostic therapeutic strategies addressing emotion regulation is a promising and new 
approach to target not only somatic symptom coping but also comorbid mental disorders 
(Kleinstäuber et al., 2016). One might develop a unified protocol, which combines both 
symptom-management techniques (e.g., relaxation exercises) and emotional processing 
components to be used by psychologists in primary care. An integrated approach may be more 
patient-centered, enhance effect sizes, and reach a greater number of people, who have different 
intervention needs. 
In conclusion, these findings provide preliminary evidence that a single, 90-minute 
interview that targets patients’ awareness about the links between their stress and health, and 
engages them in an emotional experiencing and expression exercise, reduces pain severity, 
interference, insomnia, and psychological symptoms in primary care patients with MUS. Given 
that psychologists in primary care often focus only on psychiatric diagnoses and brief symptom 
management approaches, these findings provide preliminary evidence for the importance of 
integrating an emotional component in the assessment and intervention with MUS in primary 
care. In addition, it has the potential to be a beneficial alternate approach to more traditional 
cognitive and behavioral approaches that focus on emotional down regulation or symptom 
management, for patients with MUS. These findings may inform evidence-based practice, 
improve health outcomes for patients, and reduce healthcare utilization and costs for a host of 
health conditions.  
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APPENDIX A: Interview Protocol 
 
1. Have patients complete “Before Session Ratings” 
2. Discuss ground rules for sessions (5 min) 
 
a. There are many things to cover each session, and I will keep you on track 
b. Remind the participant about confidentiality & audio recording (for supervision 
purposes) 
c. Remind them that session will run for 90mins, verify ability to participate 
 
3. Introduction (5 min) 
 
a. Rationale  
• Remind them that they’re here because they reported symptoms during their 
intake (this won’t apply for Jen); our role is helping you understand the 
potential role of stress on your health; want to see what role, if any, stress 
plays in your health 
b. Meta-communication 
i. We are going to go through a variety of questions about your life, 
including questions about your health and stressful life experiences; some 
of these might be difficult to share and some that might not be. You don't 
know me well, or how I might respond, but I encourage you to be honest 
and open with me. I know that remembering when a symptom started and 
how regularly it occurred can be difficult to remember, so please just try 
your best to give the most accurate response you can.  
 
 
4. Health History (10 mins) 
 
Goal: Get an overview of the participant’s health history, including the onset and 
development of symptoms and/or medical conditions  
 
• Let’s start by doing a brief overview of your health history (have a sheet of 
paper to fill out) 
• From birth – now (with approximate ages) 
 
a. Create a timeline with patient 
i. Health issues/symptoms  
Tell me about what kinds of health problems you’ve had in your life, 
starting in childhood until now. 
• Go over checklist of things they might have missed 
o Abdominal pains 
o IBS 
o Headaches (tension, migraine) 
o Unexplained rashes 
o Insomnia or trouble sleeping 
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o Fibromyalgia 
o Chronic pain 
o Pelvic pain 
o PMS 
o Fatigue  
o TMJ 
 
5. Stress History (30 minutes) 
Goal: to help the patient develop an awareness that their physical symptoms are linked to 
their stress/emotions 
 
Stressful life experiences, including mental health issues (anxiety/dep):  
 
Introduce the task: I want you to go through their life, from birth to now, telling me any 
stressful events or difficult experiences that you have had  
 
Meta-communication about comfort of sharing:  
I know that many of these questions can be difficult to share and they might be questions 
that you are not normally comfortable sharing with other people in your life. It is normal 
to feel somewhat uncomfortable sharing information about really difficult experiences in 
your life.  
 
(How are you feeling about sharing with me today?) 
 
(What are your concerns about sharing with me today?) 
 
(I can understand if you feel reluctant to tell me some things, but I really encourage you 
to give it a try, even if it is difficult or embarrassing or upsetting.) 
 
 
After they share, go through the checklist for issues they may have forgotten: 
 
I want you to know that many people have gone through these experiences. I will ask you 
about some specific events and situations that we know are not uncommon experiences 
for people and we want to know better what your experience with these situations is.  
 
• Checklist: have you ever experienced any of the following: 
o Serious disaster (war, explosion, earthquake) 
o Childhood maltreatment (neglect, not fed or clothed, foster care) 
o Violence between family members (e.g., hitting, kicking, 
slapping, punching)?  
o Divorce (self or parents) 
o Emotionally abused or neglected (shamed, embarrassed, ignored, 
or repeatedly told that you were “no good”)? 
o Abortion or miscarriage  
o Private health issues –STDs 
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o Has a baby or child of yours ever had a severe physical or mental 
handicap? 
o Care-giving for someone close to you who had a severe physical 
or mental handicap 
o Abused or physically attacked (not sexually) by someone you 
knew? Someone you didn’t know? 
o Harassed by sexual remarks, jokes, or demands for sexual favors  
o Touched or made to touch someone else in a sexual way because 
he/she forced you in some way 
o Have sex (oral, anal, genital) when you didn’t want to because 
someone forced you in some way 
o Have any of the events mentioned above ever happened to 
someone close to you so that even though you didn’t experience 
it yourself, you were seriously upset by it? 
o Has someone close to you died (expectedly or unexpectedly)? 
• Secrets? Conflicts or private struggles with things?  
I would like you to share something you never shared before or haven’t shared 
with me, maybe something private like a secret. You don't know me well, or how I 
might respond, but I encourage you to be honest and open with me. I can 
understand if you feel reluctant to share that with me, but I really encourage you 
to give it a try, even if it is difficult or embarrassing or upsetting. 
 
 
i. Identifying core conflicts using the checklist   
• Ask generally, what do you struggle with or have a hard time 
expressing? What do you generally avoid? What do you feel pressured 
to do or say? What are you conflicted over? 
After they share, go over examples from the list.  
• Checklist: 
Private Conflicts:  
 
o Conflicts or struggles over sexual behaviors, identity or 
relationships 
o Not fitting in or feeling ostracized (being teased or picked on, 
being shy and reserved, not being athletic or popular) 
o Feeling inferior to siblings or other relatives (not as beautiful, 
funny, athletic, interesting, accomplished) 
o Resentment and/or anger towards family members, religious 
leaders, neighbors 
 
Psychological Consequences: 
o Feeling pressure to succeed or be perfect 
o Disappointing people 
o Getting too close to people 
o People, memories, or things that you avoid? 
o Loss and abandonment (losing a parents or child, divorce) 
  
61
o Never feeling loved or cared for 
o Not trusting others; avoiding being too close, touching or too 
connected with others 
o Never feeling good enough, having to “earn” love from parents, 
feeling criticized much of the time 
o Learning to be anxious, worried, or insecure 
 
 
 
6. Experiential Component (30 minutes) 
• Applaud participants for recognizing conflict: Thank you for sharing those 
experiences with me, that was brave of you. The way these conflicts show up is 
normally in what you say and do with others in your life  
 
Rationale 
• Rationale of two core domains: dominance (independence, agency, assertiveness, power) 
and attachment (love, connecting, trust): We all have two core needs. First, to be loved, 
accepted and cared for; to be able to trust and connect to someone. Second, we have a 
need to be independent, strong, even powerful; to take care of and protect ourselves.   
These two needs show up in our important relationships.  
• Ideally, people should be free to express both needs, but what usually happens it is hard, 
at least in some relationships.  
 
SYMPTOMS: How would you rate your physical symptoms right now, on a scale from 0-
10; 0(no pain), 10(worst pain).  
 
 
Domain I: Communion  
 
Q: How can you express sadness, or love, or longing for someone? 
 
o What words or sayings can you share that help bring you closer to another person, to 
connect with them?   
• I’m sorry about what I did to you. 
• I don’t want to lose you. 
• I want to be close to you. 
• I love you. 
• Thank you for doing that for me. 
• I was wrong.  (You were right.) 
• I don’t want to hurt you. 
• I want you and me to have a closer, more genuine relationship. 
• You really are important to me. 
 
Q: What tone do you have in your voice?   
 
o It should be connecting, genuine, soft 
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Q: What posture do you show with your body?  Your face? 
 
o Demonstrate such postures…open body and arms…face soft 
 
Domain II: Agency  
 
Q:  What are some words that we use when we mean that we are angry? 
 
o Generate list of words ranging “intensity” from very low (e.g., annoyed) to very 
high (enraged, furious)  
 
Q: What posture can you use to show anger or strength?  
 
o Standing tall, proud, arms crossed 
o Standing akimbo (hands on hips/ defensive posture) 
o Pointing at someone exercise 
o Strong / angry gestures (e.g., flipping the bird, thumbing the nose, etc.) 
 
• Close your eyes and imagine someone trying to hurt your body….or take your 
children….or touch you in a way that you don’t want.   
o What does your body want to do? Your hands? 
o Picture yourself pushing that person very hard, Punching that person, Choking 
that person 
 
• How about facial expressions of anger? What do they look like?   
 
• Note: You cannot smile and be angry: smiling is usually a barrier or defense 
• How about tears instead of anger?  Usually they are learned ways to reduce your 
anger and avoid hurting someone. 
 
Q: How can your voice show anger?  
 
o Voice loudness: Many people have trouble yelling …help them do it, escalating 
the volume and intensity 
 Try “NO!” and increase in volume and intensity 
 Try “I WILL NOT” and do the same thing.   
 Try: I AM MAD AT YOU! 
 
PROMPTS: How is that for you?  How hard or easy? 
SYMPTOMS: How would you rate your physical symptoms right now, on a scale from 0-10; 
0(no pain), 10(worst pain).  
 
 
Specific Demonstrations, ASK: 
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Rationale:  
 
• Stress is very often having these two needs conflict with each other, or be suppressed.  
Stress is often being trapped when you have these important things to be expressed, but 
you feel stuck—that it is wrong or dangerous to express them. 
 
• You are doing these things in this private meeting, this doesn’t mean that we are 
encouraging you to do them in their relationships.  But that the goal here is to have you 
“try on” new ways of expressing yourself 
 
• Then, how does this apply to key people in your life?  
• Show me what it looks like to be X, Y with person Z 
• Is there a part of you what would like to express X and Y to Z 
• I’d like to do a test run of how you can express some of these important emotions  
• Take them through expressing their emotions to one or two important people who they 
have conflict with 
• Identify a conflicted relationship from the person’s stress interview. 
 
PROMPTS: How is that for you?  How hard or easy? 
SYMPTOMS: How would you rate your physical symptoms right now, on a scale from 0-10; 
0(no pain), 10(worst pain).  
 
7. Wrap up: (10 minutes) 
• What have you discovered about yourself? Your symptoms? The connections? 
• How did you feel about the interview? What were your reactions? Likes/dislikes? 
• Give them feedback, offer it as a hypothesis: This is an area of strength…etc, Seems 
like expression of anger is anxiety provoking for you, that’s pretty common, may be 
beneficial for you to work on it and get more comfortable about 
• For many people, the stress of keeping things suppressed actually contributes to their 
physical symptoms, and that relief from symptoms happens when they are able to 
express their genuine feelings. This can be done in writing, privately when you are 
alone, and even directly to a person, though when you do that, you usually need to 
communicate more gently, both of your needs (love and power)  
 
8. Complete “Post-Session Ratings” 
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APPENDIX B: Measures 
Sociodemographic Form 
 
Please answer the following questions. Complete the blanks or check the category that best describe your 
situation. 
 
1. Sex: Male/ Female 
 
2. Age: _______ 
 
3. What is the highest level in school that you completed? 
___ Less than HS or GED _____ Highest Grade Completed 
___ HS or GED (=12yrs) 
___ Some college, but less than an associate’s degree (=13yrs) 
___ Associate’s degree or two years of college (=14) 
___ College degree [e.g. BA/BS] or four years of college (=16) 
___ Master’s degree (=18 yrs) 
___ Doctoral Degree (=20 yrs) 
 
4. Ethnic Category: 
    ____________ Hispanic or Latino 
    ____________ Not Hispanic or Latino 
 
5. Racial Category: 
   _______ American Indian or Alaskan native 
   _______ East Asian (e.g. Japanese, Chinese) 
   _______ South Asian (e.g. Indian, Pakistani) 
   _______ Native Hawaiian or Other Pacific Islander 
   _______ Black of African American 
   _______ White or European American 
   _______ Middle Eastern or Arab 
   _______ Other (please describe: _________________) 
 
6. What is your current marital status: 
___ Married 
___ Separated 
___ Divorced 
___ Widowed 
___ Never married 
___ Living with a partner in a committed relationship 
 
Duration of above status: ______ (round to closest year) 
 
7. What is your current employment status? 
___ Homemaker 
___ Unemployed, but seeking employment 
___ Unemployed, not seeking employment  
___ Retired 
___ On disability 
___ Full-time employed 
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___ Part-time employed 
___ Full-time student only 
 
 
8. What is your household income? 
___ Less than $10,000 
___ $10,000 to $14,999 
___ $15,000 to $24,999 
___ $25,000 to $34.999 
___ $35,000 to $49,999 
___ $50,000 to $74,999 
___ $75,000 to $99,999 
___ $100,000 to $149.999 
___ $150,000 to $199,999 
___ $200,000 or more 
 
9. What is your current occupation? 
________________________________________ 
10. Are you currently receiving disability or workman’s compensation? 
___ Yes 
___ No 
If yes, when did you start receiving disability or workman’s compensation? _________ 
 
 
11. Are you currently in counseling or psychological therapy?  _______ Yes  ________ No 
For what? ___________________________________________________________ 
 
12. Have you ever had counseling or psychological therapy? _______ Yes ________ No 
For what? ___________________________________________________________
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MEDICAL INFORMATION AND HISTORY 
1. Primary diagnosis: _______________________ 
2. Onset of those symptoms: ____________ [record year] 
3. Date of First Diagnosis: ____________ [record year] 
4. Have you experienced pain or symptoms today?  ______Yes  ______No 
 
5. Is your health affected by any of the following medical problems? 
_____ Heart disease     _____Lupus 
_____ Diabetes     _____Scleroderma 
_____ Hypertension     _____Rheumatoid Arthritis 
_____ Chronic lung disease    _____Headaches 
_____ Cancer      _____Migraine? 
_____ Gout      _____Asthma 
_____ Stroke      _____Irritable Bowel Syndrome  
_____ Syncope/Fainting   _____Crohn’s Disease 
_____ Kidney disease     _____Ulcerative Colitis 
_____ Liver disease     _____Chronic Pelvic Pain 
_____ Ulcer or other stomach disease  _____Interstitial Cystitis 
_____ Psychiatric illness or mental disorder  _____Vulvodynia 
_____ Alcohol or drug use    _____ Other 
 
Other Medical Conditions? ________________________________________________. 
 
 
6. Height  (in feet and inches): _____________. Weight  (in pounds) : _____________. 
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ALTERNAIVE TREATMENTS INFORMATION  
 
Many people try a lot of different things to help with their health. Tell me if you have ever used or tried 
each of the following things to improve your symptoms. 
       Ever?    Past month?  
Eating healthier or changing your nutrition ………………….   
Eating herbal remedies ………………………………………           
Using over-the-counter or non-prescription medications ……   
Using street drugs such as marijuana, cocaine, or others ……   
Praying, reading the Bible, or other religious things by yourself…   
Attending religious services (includes revival, laying on of   
hands, etc.) …………………………………………………      
Acupuncture …………………………………………………….   
Biofeedback ……………………………………………      
Talking with a counselor or psychotherapist ………………      
Physical therapy …………………………………………………   
Exercise …………………………………………………………   
Imagery, relaxation, or meditation ………………………………   
Support group ……………………………………………………   
Magnets or copper bracelets …………………………………….   
Other: ______________________________________________   
          
 
 
What medications are you currently taking? 
Name of medication   Indication (for what?)   Frequency  
What vitamins and/or supplements are you currently taking? 
Name of supplement   Indication (for what?)   Frequency 
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PHYSICAL SYMPTOMS 
PHQ-15 
During the past week, how much have you been bothered by any of the following problems? 
 Not at all 
bothered (0) 
Bothered a 
little  
(1) 
Bothered a 
lot  
(2) 
a. Stomach pain  
 
  
b. Back pain  
 
  
c. Pain in your arms, legs or joints (knees, hips, etc.) 
 
 
 
  
d. Menstrual cramps or others problems with your period (women 
only) 
 
 
  
e. Headaches  
 
  
f. Chest pain  
 
  
g. Dizziness  
 
  
h. Fainting spells  
 
  
i. Feeling your heart pound or race 
 
 
 
  
j. Shortness of breath  
 
  
k. Pain or problems during sexual intercourse  
 
  
l. Constipation  
 
  
m. Nausea, gas, or indigestion  
 
  
n. Feeling tired of having low energy  
 
  
o. Trouble sleeping  
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BRIEF PAIN INVENTORY 
 
1. Please rate your pain by circling the one number that best describes your pain at its worst in the last 
week. 
 0  1 2 3 4 5 6 7 8 9 10 
    No pain            Pain as bad as 
                        you can imagine 
2. Please rate your pain by circling the one number that best describes your pain at its least in the last 
week. 
 0  1 2 3 4 5 6 7 8 9 10 
    No pain          Pain as bad as 
                       you can imagine 
3. Please rate your pain by circling the one number that best describes your pain on the average for 
the last week. 
 0  1 2 3 4 5 6 7 8 9 10 
    No pain          Pain as bad as 
                        you can imagine 
4. Please rate your pain by circling the one number that tell how much pain you have right now. 
 0  1 2 3 4 5 6 7 8 9 10 
    No pain          Pain as bad as 
           you can imagine 
 
For the next set of questions, choose the one number that describes how, during the past week, pain 
has interfered with the following activities.  Please use the 0 to 10 scale, where a 0 means that “pain 
does not interfere with that activity” and a 10 means that “pain completely interferes.” 
Does not 
interfere  
Completely 
interferes 
0 1 2 3 4 5 6 7 8 9 10 
 
a) General Activity……………………………………………0   1   2   3   4   5   6   7   8   9   10 
b) Mood……………………………………………………….0   1   2   3   4   5   6   7   8   9   10 
c) Mobility (ability to get around)……………….……………0   1   2   3   4   5   6   7   8   9   10 
d) Normal Work (includes both work outside the home and housework) 
     .……………………………………………………………0   1   2   3   4   5   6   7   8   9   10 
e) Relations With Other People………………………..……..0   1   2   3   4   5   6   7   8   9   10 
f) Sleep………………………………………………………..0   1   2   3   4   5   6   7   8   9   10 
g) Enjoyment Of Life……………………………………..…..0   1   2   3   4   5   6   7   8   9   10 
h) Self Care (taking care of your daily needs)………..............0   1   2   3   4   5   6   7   8   9   10 
i) Recreational Activities……………………………………...0   1   2   3   4   5   6   7   8   9   10 
j) Social Activities…………………………………………….0   1   2   3   4   5   6   7   8   9   10 
k) Communication With Others……………………..………..0   1   2   3   4   5   6   7   8   9   10 
l) Learning New Information or Skills………………………..0   1   2   3   4   5   6   7   8   9   10 
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Global Symptom Rating 
 
1. How would you rate your symptoms now? 
 
 
Markedly worse 
Moderately worse 
Slightly worse 
No change 
Slightly improved 
Moderately improved 
 Markedly improved 
 
 
BRIEF SYMPTOM INVENTORY 
 
Below is a list of problems and complaints that people sometimes have.  Please circle the response that 
best describes how much discomfort that problem has caused you during the past 7 days INCLUDING 
TODAY.  Please do not skip any items. 
 
    Not at all    A little bit      Moderately     Quite a bit     Extremely 
 
1.  Nervousness or shakiness inside  0             1                2                3              4 
2.  Thoughts of ending your life  0             1                2                3              4 
3.  Suddenly scared for no reason  0             1                2                3              4 
4.  Feeling lonely    0             1                2                3              4 
5.  Feeling blue    0             1                2                3              4 
6.  Feeling no interest in things   0             1                2                3              4 
7.  Feeling fearful    0             1                2                3              4 
8.  Your feelings being easily hurt  0             1                2                3              4 
9.  Feeling that people are unfriendly   0             1                2                3              4  
10. Feeling inferior to others   0             1                2                3              4 
11. Feeling hopeless about the future  0             1                2                3              4 
12. Feeling tense or keyed up   0             1                2                3              4 
13. Feeling very self-conscious with others 0             1                2                3              4 
14. Spells of terror or panic   0             1                2                3              4 
15. Feeling so restless that you couldn’t sit still 0             1                2                3              4 
16. Feelings of worthlessness   0             1                2                3              4 
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Change Assessment Questionnaire 
 
0 = Strongly Disagree 
1 = Disagree 
2 = Undecided 
3 = Agree 
4 = Strongly Agree 
 
 SD D U A SA 
1. The best thing I can do is find a doctor who can figure out how to 
get rid of my symptoms once and for all. 
 
0 1 2 3 4 
2. Even if my symptoms don’t go away, I am ready to start changing 
how I deal with it. 
 
0 1 2 3 4 
3. I am testing out some stress management techniques to manage my 
symptoms better. 
 
0 1 2 3 4 
4. My symptoms are a medical problem and I should be dealing with 
physicians about it. 
 
0 1 2 3 4 
5. I realize now that it is time for me to come up with a better plan to 
cope (e.g. stress management techniques) with my symptoms.  
 
0 1 2 3 4 
6. I use what I have learned to help keep my symptoms under control.  
 
0 1 2 3 4 
7. All of this talk about how to manage stress better is a waste of time. 
 
0 1 2 3 4 
8. I am beginning to wonder if I need to get some help to develop 
skills for dealing with my symptoms. 
 
0 1 2 3 4 
9. I have started to come up with strategies to help myself control my 
symptoms. 
 
0 1 2 3 4 
10. I’m confident that I can deal with my pain or other symptoms on 
my own. 
0 1 2 3 4 
11. I believe that my emotions and stress are the major cause of my 
symptoms. 
0 1 2 3 4 
12. I think that psychological counseling might be helpful to me to 
reduce my stress.  
0 1 2 3 4 
13. I plan to have psychological counseling to help me reduce my 
stress. 
0 1 2 3 4 
14. I am satisfied with the medical care that I am receiving at the 
(Women’s Urology Center; Crittenton Family Medicine Clinic). 
0 1 2 3 4 
15. I recommend that family or friends come to this clinic for their 
medical care. 
0 1 2 3 4 
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Symptom Interpretation Questionnaire 
 
Listed below are conditions you may or may not have ever experienced. For each condition, please circle 
the letter next to each reason or group of reasons that corresponds to how much that might explain your 
condition. Please check every item for each question. Also, answer whether you have had the condition in 
the past 3 months by circling A (YES) or B (NO). Please answer all questions. 
A B C D 
Not at 
all 
Some-
what 
Quite 
a bit 
A great 
deal 
1. If I experience pain in my body, I would probably think that 
it is because: 
My genetic vulnerability to pain A B C D 
My emotions are out of whack A B C D 
The time of day or the weather A B C D 
Have you had pain in your body in the last 3 months? A - Yes B - No 
     
2. If I experience several physical symptoms, I would probably 
think that it is because:     
My sensitive bodily tissue or makeup A B C D 
I am feeling overwhelmed A B C D 
I exerted too much effort A B C D 
Have you had several physical symptoms in the last 3 months? A - Yes B - No 
     
     
3. If I had a prolonged headache, I would probably think that 
it is because: 
I am emotionally upset A B C D 
There is something wrong with my muscles, nerves or brain A B C D 
A loud noise, bright light or something else has irritated me A B C D 
Have you had a prolonged headache in the last 3 months? A - Yes B - No 
 
4. If I was sweating a lot, I would probably think that it is 
because: 
I must have a fever or infection A B C D 
I’m anxious or nervous A B C D 
The room is too warm, I’m overdressed or working too hard A B C D 
Have you noticed yourself sweating a lot in the last 3 months? A - Yes B - No 
 
5. If I got dizzy all of a sudden, I would probably think it is 
because: 
There is something wrong with my heart or blood pressure A B C D 
I am not eating enough or I got up too quickly A B C D 
I must be under a lot of stress A B C D 
Have you felt dizzy in the last 3 months? A - Yes B - No 
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6. If I noticed my mouth was dry, I would probably think it is 
because: 
I must be scared or anxious about something A B C D 
I need to drink more liquids A B C D 
There is something wrong with my salivary glands A B C D 
Have you had a dry mouth in the last 3 months? A - Yes B - No 
 
7. If I felt my heart pounding in my chest, I would probably 
think it is because: 
I’ve exerted myself or drunk a lot of coffee A B C D 
I must be really excited or afraid A B C D 
There must be something wrong with my heart A B C D 
Have you noticed your heart pounding in the last 3 months? A - Yes B - No 
 
8. If I felt fatigued, I would probably think it is because: 
I’m emotionally exhausted or discouraged A B C D 
I’ve been over-exerting myself or not exercising enough A B C D 
I’m anemic or my blood is weak A B C D 
Have you felt fatigued in the last 3 months? A - Yes B - No 
 
9. If I noticed my hand trembling, I would probably think it is 
because: 
I might have some sort of neurological problem A B C D 
I’m very nervous A B C D 
I’ve tired the muscle in my hand A B C D 
Have you noticed your hands trembling in the last 3 months? A - Yes B - No 
 
10. If I had trouble sleeping, I would probably think it is 
because: 
Some kind of pain or physical discomfort is keeping me awake A B C D 
I’m not tired or I had too much coffee A B C D 
I’m worrying too much or I must be nervous about something A B C D 
Have you had trouble sleeping in the last 3 months? A - Yes B - No 
 
11. If my stomach was upset, I would probably think it is 
because: 
I’ve worried myself sick A B C D 
I have the flu or stomach irritation A B C D 
I’ve had something to eat that did not agree with me A B C D 
Have you had an upset stomach in the last 3 months? A - Yes B - No 
 
12. If I lost my appetite, I would probably think it is because: 
I’ve been eating too much or my body doesn’t need as much food 
as before A B C D 
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I’m worrying so much that food just doesn’t taste good anymore A B C D 
I have some stomach or intestinal problem A B C D 
Have you lost your appetite in the last 3 months? A - Yes B - No 
 
13. If I had a hard time catching my breath, I would probably 
think it is because: 
My lungs are congested from infection, irritation or heart trouble A B C D 
The room is stuffy or there is too much pollution in the air A B C D 
I’m over-excited or anxious A B C D 
Have you had a hard time catching your breath in the last 3 
months? A - Yes B - No 
 
14. If I noticed numbness or tingling in my hands or feet, I 
would probably think it is because: 
I’m under emotional stress A B C D 
There is something wrong with my nerves or blood circulation A B C D 
I am cold or my hand or foot went to sleep A B C D 
Have you had numbness or tingling in your hands or feet in 
the last 3 months? A - Yes B - No 
 
15. If I was constipated or irregular, I would probably think it 
is because: 
There is not enough fruit or fiber in my diet A B C D 
Nervous tension is keeping me from being regular A B C D 
There is something wrong with my bowels or intestines A B C D 
Have you been constipated or irregular in the last 3 months? A - Yes B - No 
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Health Care Utilization Disability Questionnaire 
    ID Number: ______ 
Phase:    Pre-treatment         1 - Follow-up         2- Follow-up          
 
Determine what the date was 3 months ago from today. Spend a few moments to recall what you have 
been doing since then, especially thinking about your health. Then answer these questions. 
 
During the last 3 months, how many times have you: 
Seen a physician or other health care professional for treatment of illness or symptoms? ___ 
Seen a physician or other health care professional for a regular checkup or preventive care? ___ 
Telephoned a physician or other health care professional, but did not visit? ___ 
Been to an emergency room? ____  (For what: ______________________________________) 
Talked to a psychological counselor or therapist? ___ 
 
 
During the past 3 months, on how many days have you: 
Missed any work or school because you were ill? ___ 
Taken any prescription medication? ___  
Taken an over the counter medication for colds, allergies, sinuses, or breathing problems? ___ 
 
 
For the next questions, respond using the scale below: 
 
0 = Never/none  1 = Very little  2 = Moderate amount 3 = Quite a bit    4 = A lot 
 
During the past 3 months, how much cigarette smoking have you done? ___ 
During the past 3 months, how often have you gotten enough sleep? ___ 
During the past 3 months, how much physical exercise have you gotten? ___ 
During the past 3 months, how often have you eaten healthy, nutritious food? ___ 
During the past 3 months, how much alcohol have you consumed? ___ 
 
 
During the last 3 months, circle a number to rate how much your health has interfered with your daily 
activities. 
 0 1 2 3 4 5 6 7 8 9 10 
No Interference         Unable to carry  
          on any activities 
 
 
Please rate your health during the last 3 months by making a mark anywhere on the line between Very 
poor and excellent.  
 
Very poor ____________________________________________________  Excellent 
 
 
Please circle a number to rate your overall stress level during the last 3 months. 
 0 1 2 3 4 5 6 7 8 9 10 
No Stress                 Unbearable str 
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Insomnia Severity Index 
 
Thinking about your CURRENT (i.e., LAST 2 WEEKS) insomnia problem (s): 
 CIRCLE the number that best describes your answer for each question. 
 
 None Mild Moderate Severe  Very 
severe 
1. Difficulty Falling asleep 0 1 2 3 4 
2. Difficulty staying asleep 0 1 2 3 4 
3. Problem waking up too early 0 1 2 3 4 
 
 
4. How SATISFIED/DISSATISFIED are you with your sleep pattern? 
 
Very satisfied 
 
0 
Satisfied 
 
1 
Moderately 
Satisfied 
2 
Dissatisfied 
 
3 
Very 
Dissatisfied 
4 
 
5. How NOTICEABLE to others do you think your sleep problem is in terms of impairing the 
quality of your life? 
 
Not at all 
Noticeable 
0 
A Little 
 
1 
Somewhat 
 
2 
Much 
 
3 
Very Much 
Noticeable 
4 
 
6. How WORRIED/DISTRESSED are you about your current sleep problem? 
 
Not at all 
Worried 
0 
A Little 
 
1 
Somewhat 
 
2 
Much 
 
3 
Very Much 
Worried 
4 
 
7. To what extent do you consider your sleep problem to INTERFERE with your daily 
functioning (e.g. daytime fatigue, mood, ability to function at work/daily chores, 
concentration, memory, mood, etc.)? 
 
Not at all 
Interfering 
0 
A Little 
 
1 
Somewhat 
 
2 
Much 
 
3 
Very Much 
Interfering 
4 
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SWLS 
 
Below are five statements with which you may agree or disagree.  Using the scale below, indicate your 
agreement with each item by placing the appropriate number on the line preceding that item.  Please be 
open and honest in your responding. 
 
1 = Strongly disagree 
2 = Disagree 
3 = Slightly disagree 
4 = Neither agree nor disagree 
5 = Slightly agree 
6 = Agree 
7 = Strongly agree 
 
____ 1. In most ways my life is close to my ideal. 
____ 2. The conditions of my life are excellent. 
____ 3. I am satisfied with my life. 
____ 4. So far, I have gotten the important things I want in life. 
____ 5. If I could live my life over, I would change almost nothing. 
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APPENDIX C: Recruitment Script and Screening Questions 
 
The text of this Recruitment Script is essentially the wording from the consent form, which we 
feel contains all of the elements that patients should know about the study.  Thus, the following 
will be stated over the phone or in person.  
 
PART I: IN-PERSON  
 
** If patient sees the flyer, then contacts the researcher in-person at the clinic to express interest 
in learning more about the study: Hi <insert the name of the individual>, thank you for your 
interest in our study, “Stress and Health Interview for Primary Care Patients with Medically 
Unexplained Symptoms”. Let me first ask you some basic questions to see if you are eligible to 
participate in the study. If so, we can go over the full study procedures [PART-II] and the written 
consent form for the study. Individuals will then be given the Information Sheet for answering 
basic screening questions.  
 
For individuals who contact us by phone, we will read the information sheet and ask the pre-
screening questions below. Then script in PART II will be used for all interested participant who 
meet the basic pre-screening criteria. 
 
Pre-Screening Questions: 
 
1. During the past 4 weeks, how much have you been bothered by any of the following 
problems? On a scale of  0 (not at all bothered); 1(bothered a little); 2 (bothered a lot) 
• Stomach pain 
• Back pain 
• Pain in your arms, legs or joints (knees, hips) 
• Menstrual cramps or other problems with your period (women only) 
• Headaches 
• Chest pain 
• Dizziness 
• Fainting spells 
• Feeling your heart pound or race 
• Shortness of breath 
• Pain or problems during sexual intercourse 
• Constipation 
• Nausea, gas or indigestion 
• Feeling tired or having low energy 
• Trouble sleeping  
 
If eligible: Great! Are you interested in learning more about our study?  
 
 
 
PART II: RECRUITMENT SCRIPT 
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THIS SCRIPT IS GOING TO BE USED IN PERSON AND ON THE PHONE AFTER 
COMPLETING THE PHQ-15 FOR PARTICIPANTS WHO QUALIFY.  
 
** Hi, my name is <insert the name of the research assistant> and I work with the research team 
at Wayne State University, who are conducting a research study for patients with medically 
unexplained symptoms. The study is being conducted by Mark Lumley, Ph.D., of the 
Department of Psychology at Wayne State University.  The purpose of the study is to conduct a 
stress and health interview to learn about your health history, the role of stress in your life and its 
contributions, if any, to your symptoms and health.  
 
If you agree to take part in this research study, you will first complete a one-hour evaluation 
session at home during which you will fill out questionnaires online about your current physical 
symptoms, your mood, your functioning, and your attitudes and beliefs. After the first evaluation 
session, you will be randomly assigned (like by the flip of a coin) to one of two conditions. You 
have a 2 out of 3 chance of being assigned to the Interview condition, and a 1 out of 3 chance of 
being assigned to a Waiting condition.   
 
If you are assigned to the Interview condition, you will be asked to return to the clinic within the 
next week for a 90-minute interview. During this session, you will meet privately with an 
interviewer. This interview will review your health history, stressful events and experiences in 
your life, explore links between your stress and health, and examine how you deal with your 
emotions and express them. At the beginning and end of the interview, you will complete a brief 
measure of your mood and symptoms. In addition, your blood pressure will be measured before, 
in the middle, and after the interview using an automated Dinamap blood pressure monitor. The 
session with the interviewer will be audiorecorded for supervision purposes. Six weeks after you 
complete the baseline questionnaires, you will be asked to complete the same questionnaires as 
you did at the first session. 
 
If you are assigned to the Waiting condition, you will wait for the interview until after your 
evaluation session that is held at 6 weeks from the baseline questionnaires. At that time, you will 
be given the option to participate in the interview session.   
 
By taking part in this study you might learn more about your health and links between your 
stress and your physical symptoms. You may also learn a new approach to reduce your stress, 
which in turn may improve your symptoms. However, we do not know whether or how much 
your symptoms may improve. Additionally, information from this study may benefit other 
people with medically unexplained symptoms.   
 
By taking part in this study, you may experience the following risks. The interview may be 
briefly uncomfortable or upsetting or may cause you to feel some anxiety. Finally, there is a risk 
that the confidentiality of your information could be lost under the following circumstances:  If 
you are thought to be at risk for self-harm or harming another, or if at any time during the study 
there is a concern that child abuse or elder abuse has possibly occurred, or if at any time during 
the study there is a disclosure of illegal criminal activities, illegal substance abuse, or violence, 
then this information may be released to the appropriate authorities.  There may also be risks 
involved in taking part in this study that are not known to researchers at this time. 
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The alternative to participating in this study is to not participate.  This study does not require you 
to change your usual medical care.  Therefore, regardless of whether or not you participate, you 
should maintain regular medical care with your physician. 
 
In the unlikely event that this research related activity results in an injury; no reimbursement, 
compensation or free medical care is offered by Wayne State University.   
 
The interview will be provided at no cost to you. If you are in the interview group, you will be 
paid $10 for each evaluation session that you complete, and $20 for completing the interview. If 
you are in the waiting group, you will be paid for each evaluation session that you complete, at 
$20 for each session; thus, you can be paid up to a total of $40. 
  
All information collected about you during the course of this study will be kept confidential to 
the extent permitted by law.  You will be identified in the research records only by a unique code 
number.  Information that identifies you personally will not be released without your written 
permission.  All data and videotapes will be kept in your study file until after 5 years or until the 
study is completed, whichever is longer, and then will be destroyed.  We will not release any 
information about you to your physician or to others unless you request us to do so.    
 
Taking part in this study is voluntary. You have the right to choose not to take part in this study. 
If you decide to take part in the study, you can later change your mind and withdraw from the 
study.  You are free to only answer questions that you want to answer. You are free to withdraw 
from participation in this study at any time. Your decisions will not change any present or future 
relationship with the Family Medicine Clinic or Wayne State University or its affiliates, or other 
services you are entitled to receive. The investigator, or the sponsor, may stop your participation 
in this study without your consent. 
 
 
What questions do you have? 
 
Are you interested in participating? 
 
 
If interested: Great, I have a few more questions that I would like to ask you to see if you qualify.  
 
 
1. Do you have any of the following conditions that could account for the elevated physical 
symptoms? 
 
• Autoimmune disease  
• Gastrointestinal disease  
• Bodily injury  
• Serious infection  
• Cancer  
• Heart disease, COPD, post-stroke 
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2. Do you have any physical or mental health problems that may prevent you from being 
able to participate in the study?  
 
a. Do you have schizophrenia or bipolar disorder? 
YES   NO 
 
b. Do you have dementia or any mental impairment?  
YES   NO 
 
3. English your first language? (If not, can you read, write, and speak English fluently?) 
YES   NO 
 
4. Are you currently in another clinical research trial of an intervention for you physical 
symptoms? 
YES   NO 
 
If eligible: Great! Do you have the time to participate in this study and attend one interview 
session if you are assigned to it? 
 
 
If the patient meets the study criteria and is interested and able to participate:  
 
Great! Let’s set up a time for you to receive your questionnaires.  
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APPENDIX D: Consent Form 
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APPENDIX E: Study model that was given to patients 
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Trauma, stress, and inhibited emotions contribute to pain and physical symptoms. People 
may disclose stressors and express emotions when encouraged, which may improve their 
symptoms. We developed an intensive interview aimed at: 1) raising patient awareness about the 
links between their stress and health; 2) engaging patients in emotional experiencing and 
expression processes. We tested its effects on patient attributions of their symptoms, in addition 
to physical and psychological outcomes in primary care patients with Medically Unexplained 
Symptoms (MUS).  
In this study, 75 patients (87% women; 79% White; mean age = 39 years) with MUS 
(e.g., localized chronic pain, fibromyalgia, irritable bowel syndrome, headaches) were recruited 
from a family medicine clinic. Participants completed self-report measures of their physical and 
psychological functioning, in addition to their symptom attributions and motivations to change at 
baseline and after 6 weeks. Then, participants were randomized (2:1 ratio) to one of two 
conditions: stress and emotion interview (n = 49) or waitlist control (n = 26) conditions. The 
interview was a single, 90-minute session in the clinic examination room, in which interviewers 
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obtained patients’ medical and life stress histories. Stress experiences were linked to pain and 
other health changes over the patients’ lives, and then patients were engaged in an experiential 
exercise to express emotions (e.g., anger, sadness) related to their stressors. Intent-to-treat 
analyses indicated that the interview condition led to significantly greater reductions in pain 
severity, pain interference, global psychological symptoms, and specifically reduced depression 
and interpersonal sensitivity at follow-up, compared to controls. Sleep problems also improved 
and contemplation to change decreased with the intervention. Contrary to hypotheses, neither 
global physical symptoms nor symptom attributions changed differentially between conditions 
over time.  
Clinical observations and patient reports indicated that the majority of patients had 
substantial unresolved victimization, conflict, and/or secrets, which typically had not been 
disclosed in this setting. Even though patients struggled to express their emotions, they were 
typically thankful and appreciative of this interview opportunity. Given that no professionals, 
including psychologists, routinely focus on these emotional issues, these findings provide 
preliminary evidence for the importance of integrating an emotional component in the 
assessment and intervention with MUS in primary care. 
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